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Vitrification is the latest technique used in cryopreservation, the ability to utilize this 
method with oocytes and embryos has become a valuable system. Vitrification has been 
successful with bovine embryos and oocytes but is far from optimal. Following 
cryopreservation storage discarding embryos can cause ethical issues, and mature oocytes 
have fragile organelles that can be detrimentally affected by ice crystal formation during 
freezing. Immature oocytes have not formed some of these temperature sensitive 
microfilaments and can circumvent these detrimental effects. The common intracellular 
cryoprotective agents are dimethyl sulfoxide, glycerol and ethylene glycol. Different 
combination of these agents have been reported for vitrification of oocytes.  
The overall objective of this experiment was to determine if immature and mature 
cumulus cell complexes vitrified in solutions of dimethyl sulfoxide or glycerol in combination 
with ethylene glycol would be competent to produce pronuclei following thawing and in vitro 
fertilization. Two experiments evaluated two cryoprotectant solutions and their ability to 
fertilize bovine cumulus cell complexed oocytes (n=400). The first study used DMSO and 
glycerol containing vitrification solution with immature bovine oocytes (n=200) followed by 
IVM and IVF with an end point of pronuclei formation to indicate fertilization. The second used 
DMSO and glycerol containing vitrification solutions with mature bovine oocytes (n=200) 
followed by IVF. We found that vitrifying immature oocytes with DMSO or Glycerol containing 
solutions prior to IVF resulted in higher fertilization for DMSO P<.01. Vitrifying mature oocytes 
with DMSO or glycerol containing also resulted in higher fertilization for DMSO solution P<.05. 
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These results suggest that DMSO may be the more appropriate choice when used in 






In vitro embryo production (IVP) including in vitro maturation (IVM), in vitro 
fertilization (IVF) and in vitro culture (IVC) is an invaluable tool for human fertility clinics as 
these assisted reproductive technologies help to provide infertile men and women with 
children of their own (Hansen, 2013).  IVP is also a valuable tool for commercial livestock 
production due to the fact that it increases the number of offspring that can be produced from 
each animal per year (Hansen, 2013). Through the use of transvaginal ultrasound guided 
oocyte pickup, it is possible to retrieve many oocytes per cow on a weekly basis. These oocytes 
can then be matured and fertilized in vitro before transfer into recipient cattle to produce 
many viable embryos and offspring (Hiroyoshi, 2002). This is especially useful for maximizing 
the offspring potential of genetically valuable animals.  
 In vitro production can be further maximized through use of cryopreservation for long 
term oocyte storage (Shaw and Troson, 2000). However, cryopreservation of embryos can be 
costly, hard to manage, and at times may pose moral and ethical issues. Cryopreserving 
mature oocytes can result in damage to the metaphase spindle due to the temperature 
sensitivity of microfilaments and microtubules as well as other morphological issues (Baka et 
al, 1995). Cryopreservation of immature oocytes may circumvent this problem because these 
structures have not yet formed and the genetic material is enclosed within a nuclear envelope 
(Benson, 2008). Cryoprotectants, such as dimethyl sulfoxide and glycerol, help to prevent ice 
crystal damage during cryopreservation (Fuller, 2004). There has been discussion on which 
cryoprotectant and concentration works better for certain cell types and sizes. Recent studies 
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have also shown that a newer technique, termed vitrification, results in a significant 
improvement over the traditional slow-rate freezing procedure (Lawson, 2011). These results 
vary with cell type, cell size and species used in vitrification, a fast freezing technique that 
transforms a liquid into a glass like structure. It has also been shown that intact cumulus-
oocyte complexes (COC) are essential for normal maturation and should be intact during the 
vivo or vitro maturation and fertilization periods (Senger, 2005).  
The overall goal of this research is to determine if immature and mature COC’s 
cryopreserved via vitrification with dimethyl sulfoxide (DMSO) or glycerol will form pronuclei 
following thawing and in vitro fertilization, indicating viability. This study will compare DMSO 
and glycerol cryoprotectants within each oocyte group. Survival rates will be compared to 
determine if it is possible to vitrify immature oocytes as an alternative to mature oocytes for 
future cryopreservation procedures. This will help to determine which cryoprotectant has a 
higher survival rate with bovine oocytes, immature or mature and determine whether one 
cryoprotectant treatment may be optimal for a particular oocyte stage and identify whether or 














Gamete cryopreservation was initially established primarily for use in male infertility 
treatments, but has since expanded to become an important tool in many aspects of assisted 
reproduction (Bunge, 1954). Fowl spermatozoa were first cryopreserved in 1949 using glycerol, 
thus making them the first mammalian reproductive cells to be successfully frozen, (Polge and 
Parks, 1949) and remain the easiest gamete to freeze today. The development of techniques 
for cryopreservation of human spermatozoa for use in human reproduction is credited to 
Sherman and Bunge’s work in the mid 1950’s (Bunge and Sherman, 1954). The use of glycerol 
was further studied in the 1950’s to attempt cryopreservation of  unfertilized mouse oocytes 
(Sherman, 1959) and rabbit zygotes (Smith, 1953) but with minimal success. Cryopreservation 
of oocytes and their ability to become viable embryos proved more challenging than 
cryopreservation of the spermatozoa cells, mainly because many procedures caused damage 
to the zona pellucida (Shaw, 2000, Baka, 1995, Magistrini and Szollosi, 1980). Another problem 
was thought to be due to the meiotic spindles sensitivity to cold temperatures, causing 
irregularities in meiosis (Shaw, 2000 and Baka, 1995). This was demonstrated in mouse 
oocytes where upon return to 37°C, the spindle would reorganize in an abnormal shape with 
the chromatids scattered throughout the ooplasm (Pickering, 1987). This was believed to be a 
possible cause for increased aneuploidy in cryopreserved oocytes (Pickering, 1987). In the 
1980’s cryopreservation protocols for embryos and spermatozoa success was established 
resulting in live mice births (Pickering, 1987). Other studies at the time raised concerns about 
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fertilization of cryopreserved mature oocytes after observations of physical damage (Todorow, 
1989) and structural modifications to the zona pellucida (Todorow, 1989). These studies 
established the necessity for a slow cooling cryopreservation protocol for oocytes and 
cleavage-stage embryos. Successful cryopreservation of spermatozoa and embryos has made 
assisted reproductive technologies (ART) more practical and available for commercial use 
(Baldassarre and Karatzas, 2004). The advantages of cryopreservation being the ability to 
transport gametes long distances, to remove the requirement of estrous synchronization and 
therefore reduce the number of recipients required (Do and Taylor-Robinson, 2014). There are 
now a range of cryopreservation protocols that can be used to preserve both mature and 
immature oocytes, embryos and spermatozoa.  
OOGENESIS 
In mammals, oogenesis (the development of an oocyte) begins early in fetal 
development and ends months to years later in the sexually mature female, puberty. 
Oogenesis begins with primordial germ cell formation (Senger, 2005). Once established they 
are then referred to as oogonia and will eventually undergo a final round of DNA replication 
before entering meiosis and becoming oocytes. After puberty oocytes will enter meiotic 
prophase one before arresting at the diplotene phase. This arrest is maintained until the 
dominant follicle is stimulated by a gonadotropin surge (Senger, 2005). Oocytes must grow in 
follicles to become competent to resume nuclear maturation and undergo fertilization and 
cleavage divisions. When oocyte growth is complete they are capable of progressing through 
germinal vesicle breakdown and resume meiosis. During the oocytes growth phase, the 
oocytes undergo a complex reorganization of organelles within the cytoplasm. Replication of 
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the cytoplasmic organelles during oogenesis, specifically the mitochondria and mitochondrial 
DNA, is crucial as the cytoplasmic inheritance of the zygote originates in the oocyte (Alberts, 
2002). During oocyte growth phase, the mitochondria rapidly multiply, and organelles become 
less active. Within the maturing oocytes ribosome numbers increase and organelles move 
towards the cell periphery (Senger, 2005). As the oocyte continues to grow an increasing 
number of pores appear in the nuclear membrane around the nucleolus, indicating the 
beginning of maturity (Alberts, 2002). At the end of the growth period and just before meiotic 
maturation, the oocyte nucleus is large, pale, and immature, referred to as a ‘germinal vesicle’ 
(GV) (Senger, 2005). Once the dominant follicle is stimulated the primary oocyte starts to 
develop into an ootid, through resumption of meiosis. This stage occurs after puberty and 
development continues to a secondary oocyte with extrusion of the first polar body, these 
oocytes are now considered mature and are ready for ovulation and fertilization (Senger, 
2005).  
  Surrounding both immature and mature oocytes are layers of cumulus cells. These cells 
develop from specialized granulosa cells that differentiate into mural granulosa cells and 
cumulus cells during follicular antrum formation. Cumulus cells are biologically different from 
other follicular cells and execute specific roles including, transmitting signals within the ovary 
and supporting oocyte growth and maturation during the later stages of follicular 
development (Senger, 2005). They surround and nourish the oocyte. The communication 
between cumulus cells and oocytes is bidirectional and imperative for regulating both oocyte 
and cumulus cell development. Oocytes have fewer energy sources than necessary for proper 
oocyte growth so the cumulus cells are needed to transfer energy to the oocyte through gap 
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junctions (Franciosi et al., 2014). After the luteinizing hormone surge, granulosa cells produce 
epidermal growth factors that act on cumulus cells to induce cumulus expansion and oocyte 
maturation (Hung et. al, 2015). Cumulus cells regulate oocyte growth, oocyte maturation and 
the fertilization process (Da Costa et. al, 2015). A high proportion of fertilized oocytes express 
an abnormal fertilization rate following maturation when there is an absence of cumulus cells 
around the oocyte. Matured oocytes with intact cumulus cells before fertilization were able to 
develop to viable fetuses at similar rates to ovulated oocytes after in vitro fertilization 
(Vanderhyden and Armstrong, 1989). This demonstrates the  essential role for cumulus cells in 
assisting normal cytoplasmic maturation of oocytes necessary for pronuclear formation and 
complete developmental capacity (Vanderhyden and Armstrong, 1989). In another study 
completed by Jin and associates, it was concluded that the maintenance of cumulus cells can 
improve the developmental ability of vitrified thawed mature human oocytes resulting in 
successful pregnancy. In comparison, oocytes with the cumulus cells removed prior to 
cryopreservation had a significantly lower fertilization rate (Jin et. al, 2012). An additional 
study by Purohit found that immature cumulus enclosed compact goat oocytes better tolerate 
cryopreservation stress, as assessed by fertilization rates when compared to immature, 
denuded and in vitro matured oocytes (Purohit et. al, 2012). In conclusion cumulus cells are 
needed on oocytes regardless of maturity, especially with in vitro maturation of the oocytes. 
COLLECTION 
  While there are different methods for the recovery of oocytes, aspirating follicles from 
ovaries of slaughtered animals is currently the most common procedure. However, due to its 
terminal nature, this technique cannot be repeated on any single animal (Hashimoto et. al, 
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1999). To continually repeat collection of bovine oocytes from naturally cycling cows, the 
transvaginal ultrasound guided follicular aspiration technique (TUGA) was developed (Pieterse 
et. al, 1988). With TUGA, an epidural anesthetic is normally given to prevent abdominal 
straining and to ease palpation. The standing cow is restrained so that little movement is 
possible during oocyte collection (Manik and Palta, 2003). After retraction of the uterus the 
right or left ovary is placed against the head of the transducer which had been inserted into 
the vagina adjacent to the cervix. The antral follicles appear as black round spots on the 
monitor of the scanner and the puncture needle is depicted by a hyperechoic line going into 
the ovary (Manik and Palta, 2003). The transducer is positioned so that the puncture line on 
the monitor transects the follicle to be punctured. When a follicle is positioned steadily on the 
puncture line, the needle will be pushed through the vaginal wall until its tip becomes visible 
within the follicle (Pieterse et. al, 1991). This is directly followed by aspiration of the follicular 
contents. After the needle is withdrawn from the ovary and the transducer from the vagina, 
the needle is flushed with phosphate-buffered saline solution (PBS). The fluid of each follicle is 
collected in a filter and inspected for the presence of an oocyte (Pieterse et. al, 1991). 
CRYOPRESERVATION 
Cryopreservation of oocytes enables scientists to store oocytes long term from patients 
that are in danger of losing ovarian function, while relieving many of the ethical concerns 
associated with embryo cryopreservation (Shaw and Troson, 2000, Baka et. al, 1995). The first 
challenge in cryopreserving cells from warm-blooded animals is in cooling the cells below body 
temperature. Cells may incur damage, referred to as chilling injury, from the low temperatures 
(Baka et.al, 1995). Cryopreservation is the use of very low temperatures to preserve intact 
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living cells and tissues at approximately -196°C. At these low temperatures, all biological 
activity stops, including the biochemical reactions that lead to cell death and DNA degradation 
(Shaw and Troson, 2000).  Water is the major component of all living cells and must be 
available for the processes of life to occur, cellular metabolism stops when water in the 
structure is converted to ice crystals. The behavior and function of membrane lipids and 
proteins may be affected during the freezing process as well (Shaw and Troson, 2000). 
Cryopreservation relies on the ability of small molecules to enter the cell’s cytoplasm and 
prevent both dehydration and formation of ice crystals within the cell. Ice crystals form at 
different times during the freezing process.  At temperatures at or below 0°C, water resists the 
breaking of hydrogen bonds and the molecules lock together, this creates pockets of open 
space between tight parts of the structure where ice crystals may form (Pickering, 1987). Ice 
crystals have the capacity to grow into complex clusters forming networks that can grow 
exponentially as more and more water molecules interact to form increasingly complex 
crystals. Ice nucleation affects the structural, osmotic, and colligative integrity of cells causing 
physical ruptures and mechanical injury (Benson, 2008). With the help of cryoprotectants ice 
does not begin to form until about -5°C. Extracellular water begins to freeze between -5 and -
15°C but the cell contents remain unfrozen and super cooled. The plasma membrane blocks 
the growth of any ice crystals into the cytoplasm (Albrecht, 1982) and the water within the cell 
has a higher chemical potential than the water that is partially frozen outside of the cell, 
therefore the water flows out of the cells to freeze extracellularly (Albrecht, 1982).  The actual 
physical events within the cell depend on the cooling speed (Alink and Offerigns, 1977). When 
cooling the cell slowly, the cell is able to lose water by exosmosis.  The cell will then dehydrate 
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and intracellular freezing will be avoided. During rapid cooling, the cell is not able to lose water 
fast enough to maintain the equilibrium between the external and intercellular membranes, it 
becomes increasingly super cooled and will eventually reach equilibrium by the intracellular 
freezing as a glass like substance (Alink and Offerigns, 1977).  
Scientists are challenged with stabilizing replicable genetic material to preserve it 
unchanged.  The aim of cryopreservation is to enable cells to be stored and to prevent the 
need to have all cell lines in culture at all times. This is invaluable when dealing with cells of 
limited life span.  Other main advantages of cryopreservation are the reduced risk of microbial 
contamination, the reduced risk of cross contamination with other cell lines, the reduced risk 
of genetic drift and morphological changes, and the reduced costs (Sigma,2010). 
Cryopreservation also plays an important role in assisted reproduction, it enables the 
reproductive cells collected and/or fertilized in one treatment cycle, to be used for fertilization 
and/or implantation into the uterus in a future treatment cycle.  
CRYOPROTECTANTS 
Cryoprotectants (CPA) is the functionally derived term created to describe any additive 
which can be provided to cells before freezing to yield a higher post thaw survival than can be 
obtained in its absence. The first recorded example of deliberately adding a cryoprotectant, 
was the works of Polge and colleagues (Polge and Parks, 1949). They established factors for 
success of cryoprotectant activity of a particular solute, the addition of glycerol (Polge and 
Parks, 1949). In order for the cells to survive the cryopreservation process, they must maintain 
intact organelle membranes and have no intracellular ice crystal formation (Agca et. al, 1998). 
Cryoprotectants guard the cell during freezing, are nontoxic in low concentrations and are 
10 
 
inexpensive (Felipe de Lara Janz et. al, 2012). Cryoprotectants also help to ensure high levels of 
cell viability post thaw, and lower freezing temperatures allowing for greater dehydration of 
cells before water freezes (Watson, 1995). Cryoprotectants act not only as an osmotic gradient 
to aid in the water movement across the membrane, but also as antifreeze, to reduce the 
temperature at which ice crystals form. Cryoprotectants are separated into two main classes 
intracellular agents, and extracellular agents. Intracellular agents include ethylene glycol, 
dimethyl sulfoxide, and glycerol, these penetrate inside the cell preventing the formation of 
intracellular ice crystals that could result in membrane rupture or destruction. Intracellular 
cryoprotectants have low molecular weight and amphipathic properties, permeate cells and 
are effective in minimizing cell damage in many slow frozen biological systems (Agca et. al, 
1998). These are the most commonly used cryoprotectants, with glycerol being the most 
widely used. Glycerol is a small trihydroxy sugar alcohol, poly-hydroxylated solute with high 
solubility in water, and low toxicity to living cells with short exposure periods. It can interact by 
hydrogen bonding with water, and can permeate across the plasma membrane of many 
different cell types (Agca et. al, 1998). Cells may tolerate exposure to glycerol in 
concentrations between 1 to 5 mol/L, depending upon cell type and conditions of exposure 
(Fuller, 2004). There are many debates about which intracellular cryoprotectant to use when 
freezing as dimethyl sulfoxide, glycerol and ethylene glycol are comparable to one another in 
many respects. In recent studies dimethyl sulfoxide has been used more often for oocytes and 
embryos (Schellander et. al, 1994). In one particular study dimethyl sulfoxide treatment led to 
significantly better cleavage and development up to 4-cell stage in oocytes cryopreserved at 
the MII stage. However, development beyond the 8-cell stage was obtained only when 
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immature oocytes were frozen (Schellander et. al, 1994). It was found that when using glycerol 
and 1,2- propanediol in vitrification of bovine blastocysts the success following the 16 step 
equilibration minimized the ultrastructural damage to the plasma membrane during freezing 
and therefore ice crystal formation (Kuwayama and Nagai, 1994). In another study it was 
noted that when vitrifying immature and mature equine and bovine oocytes in ethylene glycol 
that the maturation rates after vitrification were higher in bovine oocytes than equine at 70% 
and 30%, respectively (Hurtt et. al, 2000). Depending on the source consulted, there have been 
variable results on the relative toxicity of the different cryoprotectants, with disagreement on 
which is the least toxic (Lawson and Sambanis, 2011, Huang et. al, 2006, Aye et. al, 2010, 
Comizzoli and Pukazhenthi, 2004). Many factors for optimizing cryopreservation are 
dependent on the cell type and species including cryoprotectants used, experimental protocols 
and thawing time. 
The second class of cryoprotectants are extracellular cryoprotective agents, such as 
sucrose, trehalose, or dextrose. These do not penetrate the cell membrane and act to improve 
the osmotic imbalance that occurs during cryopreservation. Extracellular CPA’s can also be 
used entirely on their own, to increase the osmolarity of extracellular solution, to help draw 
water out of the cells. Osmotic imbalance occurs within the cell when water is removed from 
the extracellular environment and the water going through the cell membrane is moved out of 
the cell. When the extracellular solute concentration is too high and water moves out of the 
cells rapidly, it can be harmful. If too much water is inside the cell during cryopreservation, ice 
crystals will form and recrystallization during thawing can occur and lyse the cell.  Felipe de 
Lara Janz stated that when cells were preserved in sucrose and trehalose alone they had a low 
12 
 
rate of stem cell viability and therefore had an increase in lag phase after thawing (Felipe de 
Lara Janz et. al, 2012). These problems occurred due to the fact that extracellular agents alone 
do not adequately prevent the formation of ice crystals within the cell. The combination of  
 
 
both cryoprotectant agents can optimally preserve cells but there are many factors that need 
to be evaluated for each individual experiment before creating a protocol. The concentration 
System Type/cause of damage 
All Intracellular ice formations, extracellular ice formation, apoptosis, 
toxicity, calcium imbalance, free radical, ATP levels, general 
metabolism, fertilization failure, cleavage failure, pHi, 
parthenogenetic activation,  
Membrane Rupture, leakage, fusion, microvilli, phase transition 
Chromosomes Loss/gain, polyspermy, polygyny (failure to extrude polar body), 
tertrapliody 
DNA Apoptosis, fusion, rearrangements 
Cytoskeleton Microtubules dissolve, actin 
Proteins/enzymes Dehydration, loss of function 
Ultrastructure Microvilli mitochondria, vesicles, cortical granules, zona pellucida 
Zona Pellucida Hardening, fracture 
Lipids Free radical? 
Table 2.1 Factors Associated with Cooling and Cryopreservation that Contribute to Cellular 




of cryoprotectants, the combination of cryoprotectants, length of exposure time to each 
solution, and other factors affect the viability of the cells being cryopreserved. Table 2.1 shows 
the type and cause of damage during cryopreservation within the biological system (Shaw and 
Troson, 2000). 
High concentrations of cryoprotective agents can be damaging to cells (Meryman, 
1971). In general, vitrification requires a two to three step procedure of moving cells through 
increasing concentrations of cryoprotective agents to minimize osmotic shock (Meryman, 
1971). The first solution consists of low concentration to remove the majority of the water 
from the cell often referred to as an equilibrating solution. The second and third solutions 
consist of higher concentrations with the cells only exposed for a brief time to minimize the 
risk of toxicity. A study showed that reducing the amount of time of exposure to vitrification 
solutions can reduce the risk of toxicity to the cell (Ishimori et. al, 1993). Another study 
completed by Yamada and colleagues compared the efficiency of vitrifying immature oocytes 
in different combinations of ethylene glycol, glycerol and dimethyl sulfoxide at various time 
intervals. In the first experiment, oocytes were exposed to the cryoprotectant for either 30 or 
60 seconds in final solutions of 20 % ethylene glycol + 20% dimethyl sulfoxide or 25% ethylene 
glycol +25% dimethyl sulfoxide. In the second experiment, the oocytes were vitrified in open 
pulled straws (OPS) using a 30 second exposure to final solutions as above. The post-thaw 
maturation rates showed that a 30 second exposure did not differ from the control groups but 
that a 60 second cryoprotectant exposures was toxic to the cells, reducing the maturation 
rates. The second solution of 25% ethylene glycol + 25% dimethyl sulfoxide enhanced the 
maturation rates compared to the other solutions used. The concentration of cryoprotectants 
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used in this study showed their importance on the post thaw development and survival rate of 
vitrified oocytes (Yamada et. al, 2007). Si and colleagues found that glycerol at concentrations 
below 5% in comparison to 15% dimethyl sulfoxide led to improved post-thaw survival (Si et. 
al, 2004). In addition to all these different factors the cooling rate has been proven to have a 
significant impact on long term cell viability (Fasano, 2014). Not only does cooling rate affect 
the rate of formation and size of both intracellular and extracellular ice crystals; it can also 
impact solution effects that occur during the freezing process (Fasano and Vannin, 2014). 
There are two main freezing procedures that are used today; slow rate cryopreservation and a 
fast freezing method termed vitrification. 
SLOW RATE CRYOPRESERVATION 
Most oocyte and embryo cryopreservation systems use a controlled rate freezer for a 
process known as slow rate cooling or conventional cryopreservation. This freezing system 
leads to the extracellular solution freezing before intracellular ice crystals form creating an 
osmotic imbalance across the cell membrane leading to the water leaving the cell. Liquid 
nitrogen is poured into a closed chamber system that is connected to a computer system, 
controlling the rate at which the internal chamber, where cells are placed, is cooled. During 
this process there was an increase in the solute concentration outside and inside the cell due 
to ice crystal formation, this can be detrimental to cell survival (Mavrides and Morroll, 2002). 
The freezing rate is set to optimize cell dehydration and so prevent intracellular ice crystal 
formation. The embryos or gametes are placed into a programmable freezer that can be set 
and reduced to any temperature. One common protocol starts at 23°C and reduced -2°C per 
minute to -8°C then seeded and held for 5 minutes. The system then reduces -0.3°C per 
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minute to -30°C, -50°C per minute to -140°C and held for 15 minutes. This can take anywhere 
from an hour to three hours, depending on the set cooling rate, but allows many cells to be 
frozen at the same time (Mavrides and Morroll, 2002). The frozen suspension is then 
transferred to a liquid nitrogen tank and maintained at subzero temperatures for 
indeterminate lengths of time.  The consequences of this slow and gradual freezing process 
have been documented to include cellular injury, resulting in cell death, especially from -15°C 
to -30°C (Djuwantono et. al, 2011). Cells pass through this critical range twice; during freezing 
and again during thawing. The transition of the cells from fluid to solid state could also cause 
osmotic injury. In recent literature, the survival of cryopreserved human oocytes following 
slow rate freezing ranged from 74% to 90%(Chen and Yang, 2009). About 85% of slow rate 
frozen matured oocytes had normal morphological characteristics in another study (Sinha 
et.al, 2014). Bianchi questioned if the cryopreservation machine may be obsolete in a study 
performed in 2012 (Bianchi et.al, 2012) concluded that in infertile human couples undergoing 
in vitro fertilization treatments he found that slow freezing of oocytes can be a valid tool still in 
practices with in vitro fertilization when using suitable protocols (Bianchi et. al, 2012). A study 
aimed to evaluate the ability of slow freezing for cryopreservation of immature, germinal 
vesicle porcine oocytes found that slow freezing is a feasible approach for cryopreservation of 
porcine germinal vesicle oocytes when the correct cooling rate is used. The results indicated 
that the cooling rates of 6, 3 and 1.5°C per minute could be considered as possible 
cryopreservation protocols when using 2.0M DMSO (Yang et. al, 2012). This study also verified 
an effective approach for optimal cooling rates by evaluating the intracellular ice crystal 
formation characteristics of porcine germinal vesicle cumulus cell complexed oocytes (Yang et. 
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al, 2012). Literature reviews have shown that the majority of pregnancies to date have been 
accomplished with a slow freezing protocol (Oktay and Bang, 2006). Both slow rate freezing 
and vitrification methods for oocyte cryopreservation can be used effectively with subsequent 
successful pregnancies (Oktay and Bang, 2006). However, recent improvements in the 
vitrification technology have enhanced its effectiveness and because of its simplicity made it 
the method of choice in oocyte cryopreservation. 
VITRIFICATION 
Vitrification is a fast freezing technique, that transforms liquid into a glass like state 
without ice crystal formation. It was developed in 1985 and requires no expensive 
programmable freezing equipment (Rall, 1985) unlike the slow-freezing process. It relies on an 
extremely high concentration of CPAs to create highly viscous solutions in which ice crystals 
cannot form, rather than relying directly on cell dehydration (Rall, 1985). Rall first showed that 
a murine embryo could be successfully cryopreserved, but the vitrification solution they used 
was highly toxic (Rall, 1985). Later studies by Rall were successful with live mice born following 
embryo vitrification (Rall, et al. 1987). The combination of ethylene glycol and dimethyl 
sulfoxide with sucrose was reported for mouse (Ishimori, et al. 1993) and bovine embryos 
(Ishimori, et al. 1993), and form the basis of the vitrification protocol in assisted reproduction 
treatment. By the end of the 1990’s, vitrification was being applied to human embryos with 
high survival leading to blastocyst development and pregnancy establishment (Hsieh, et al. 
1999). Lately there has been increased interest in cryopreservation of oocytes. The desire to 
preserve fertility in young women undergoing gonadotoxic treatments or restrictions by 
embryo cryopreservation in some countries including Bangladesh, El Salvador, Germany, 
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Switzerland and Italy, has led to the necessity of oocyte donation or oocyte preservation for 
fertility maintenance (Gook, et al. 2012). Many studies have shown that vitrification of 
matured bovine oocytes have very high survival rates, and (Dalvit, et al. 2012) reported a 99% 
survival rate after thawing. In the same study oocytes were matured and fertilized in vitro and 
cultured to the blastocysts stage prior to vitrification. After thawing the morphology was 
evaluated and showed 100% survival. The rest of the vitrified blastocysts were transferred to 
recipient heifers, with fifteen heifers becoming pregnant which resulted in the birth of eleven 
calves. Pregnancy rates with in vitro produced embryos showed no difference compared to 
fresh blastocysts. Dalvit and others concluded that successful vitrification is possible when 
using bovine oocytes and embryos. They further noted that the survival and developmental 
rate are very similar to one another when comparing vitrified thawed oocytes and fresh 
oocytes (Dalvit, et al. 2012).  Vitrification normally consists of two to three solutions that are 
prepared in TCM-199 with 10% fetal bovine serum (FBS). The equilibration solution consists of 
a relatively low concentration of cryoprotectants which is then increased in the second or third 
solution. These solutions also contain sucrose or trehalose as an extracellular cryoprotective 
agent (Kuleshova et. al, 1999). A study done by Dutta and colleagues evaluated the post-thaw 
developmental competence of vitrified bovine cumulus-oocyte complexes in vitro. Oocytes 
were aspirated from three to eight millimeter ovarian follicles and cryopreserved via 
vitrification (Dutta, et al. 2013). They used two vitrification solutions in TCM 199 and 10% FBS, 
7.5% ethylene glycol and 7.5% dimethyl sulfoxide followed by 15% ethylene glycol, 15% 
dimethyl sulfoxide and 0.6M sucrose. The immature oocytes were placed into the first solution 
for three minutes followed by 30 seconds in the second solution at room temperature. The 
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oocytes were then immediately loaded into 0.25mL French straws that were preloaded with 
0.6M sucrose in the holding medium with air gaps in between and plunged directly into liquid 
nitrogen. During the thawing stage straws were put into a 37°C water bath for 30 seconds and 
were gradually rehydrated in 0.6M sucrose solution for one minute. After washing, the 
morphology of the cells was assessed and put into vitro maturation. After 24 hours in the 
maturation medium they were then subjected to in vitro fertilization. In the vitrified group in 
vitro maturation on the basis of cumulus cells expansion was more than 80% and the unfrozen 
control had 93% maturation showing that vitrification had minimal effect on the survival rates 
and the ability of the oocytes to mature in vitro.  High proportions of the oocytes retained 
their post thaw morphology after short exposure to high concentrations of permeating 
cryoprotectants with sucrose. Overall this protocol for vitrification had minimal effects on 
survival rates and the ability for the oocytes to mature in vitro (Dutta, et al. 2013).   
Different procedures and protocols work as well and solution concentrations can be 
variable, and the amount of time in each solution may differ, as a single optimum protocol has 
not been established. In another study, Luvoni evaluated the effect of vitrification of feline 
ovarian cortex on follicular morphology and oocyte integrity, as well as meiotic competence. 
Oocytes that were isolated from vitrified tissues were able to resume meiosis (39.8%), showing 
that vitrification preserves the integrity of ovarian follicles and that oocytes that are taken 
from cryopreserved tissues can maintain the ability to resume meiosis (Luvoni et. al, 2012). 
Vitrification is technically simpler and may be more effective than slow freezing. In one study 
by Cao slow freezing and vitrification were compared with evaluation of survival, early 
embryonic development, fertilization, meiotic spindle assembly and chromosome alignment in 
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frozen thawed human oocytes (Cao et. al, 2009). The oocyte survival in the slow cooling group 
was significantly lower than those in the vitrification group and the fertilization rate was the 
same for both groups. When looking at the cleavage rate the vitrified zygotes had a 
significantly higher proportion than the slow cooling. Even when looking at the high quality 
embryos the post-vitrification survival was double that seen with slow cooling, including the 
percentage of blastocyst development. There was a much higher percentage of oocyte 
abnormalities in terms of spindle assembly and chromosome alignment in the slow freezing 
group. Overall vitrification was superior to the slow freezing method in terms of survival 
fertilization and developmental rate for human matured oocytes in this study (Cao, et al. 
2009). In comparison Prentice (2011) found that maturation rate was low in vitrified immature  
 
bovine cumulus cell complexed oocytes compared to slow freezing controls, with cleavage and 
blastocyst rates being higher in controls. Her results showed that the vitrification procedure 
damaged the bovine cumulus cells oocyte complexes resulting in poor nuclear maturation and 
embryo development (Prentice et. al, 2011). At present, approximately equal numbers of 
 Slow Rate Freezing Vitrification 
Survived/ cryopreserved rate 1730/1944 (89%) 5881/5881 (100%) 
Cleaved/surviving rate 1557/1730 (90%) 5469/5881 (93%) 
Blastocyst/cleaved rate  7961/1557 (51%) 3058/5469 (56%) 
Blastocyst/cryopreserved rate 7961/1944 (41%) 3058/5881 (52%) 
Table 2.2 Survival and development rate of human pronuclear embryos cryopreserved by 




babies have been born from both techniques (Noyes et. al, 2009). Table 2.2 shows the 
differences between slow rate freezing and vitrification in Valojerdi (2009) study showing the 
survival and development rate of human pronuclear embryos. These results showed that 
vitrification may be the superior cryopreservation technique with human embryos (Valojerdi, 
2009).  It would appear that there is a role for both procedures today and in the future. 
Vitrification is a fast, efficient, and economical method for oocyte cryopreservation providing a 
new alternative for the management of female infertility and fertility preservation options.  
CRYOPRESERVATION TOOLS 
When vitrifying, it is ideal to minimize sample volume in order to achieve very rapid 
cooling and warming rates. Cryopreservation would not be possible without a safe, secure 
container for oocytes and embryos to be frozen in. There are many possible carriers to 
minimize the volume of vitrification solution that is used today. The most common are open 
pulled straw, cryoloop, cryotop, and cryolock. Cryotop systems consist of a fine, transparent 
polypropylene film attached to a plastic handle and equipped with a cover straw, in which cells 
can be loaded in a very small volume.  Cryotops have been successfully used to cryopreserve 
cow and buffalo embryos (Laowtammathron et. al, 2005) and oocytes (Chian et. al, 2004). 
Open Pulled Straws (OPS) were especially designed for vitrification, and are an open system 
allowing for even faster cooling rates. Techniques are categorized as either 'open' or 'closed' 
according to occurrence of direct contact between the medium and liquid nitrogen during 
cryopreservation. Scientists who use open systems refer to the lack of evidence of disease 
transmission in an open system and regard their systems as more consistent and efficient 
(Vajta et. al, 2015). Cells can also be packaged into straws, which are then sealed on both ends 
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before plunging into liquid nitrogen to ensure that contamination is prevented.  When 
comparing cryotops to open pulled straws a lower percentage of those oocytes vitrified in the 
open pulled straw had a normal spindle configuration compared to fresh oocytes, while 
normal spindle and chromosome configurations were observed more consistently in the 
cryotop vitrified bovine oocytes. This suggests that the cryotop system is a more efficient 
carrier for vitrification of bovine oocytes than open pulled straws (Morato et. al, 2008). The 
cryoloop method is a new technique where a thin nylon loop is used to suspend a film of 
cryoprotectant containing the oocytes to directly submerge them in liquid nitrogen. The loop 
shows minimal diffraction, is thin for fast freezing and is aerodynamic. In one experiment the 
cryoloop vitrification method produced a survival rate of 90.5% compared to the traditional 
slow freezing technique that yielded a rate of 54.4% (Mavrides and Morroll, 2002).  Cryolock is 
a square shaped stick, with four flat surfaces. It has a concave tip, where the cells, oocytes or 
embryos are placed, it provides protection to the cell against contact with other surfaces, 
avoiding loss or damage of samples. During slow rate freezing there are many tools needed 
that include a secure container for oocytes and embryos to be frozen in. This is normally an 
0.25mL straw that contains a plug, as a straw is needed for the programmable freezer control 
unit. In most programmable freezers, the straws are cooled by nitrogen vapor. The 
temperature inside the cooling chamber can be accurately controlled and the time course of 
the temperature can be programmed. The rate of heat exchange is governed by the 
temperature difference between the inside and the outside of the straw (Sansienen et. al, 
2010) . When using both techniques the tools are very important aspects that need to be 
evaluated before cryopreservation. The freezing process is not the only concern for harmful 
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effects on the cell, there are many factors that can change the viability. One main issue with 
vitrification and slow rate freezing is the thawing process after vitrification and slow rate 
freezing.  
WARMING 
Freezing cells allows them to be stored for years in a state where their normal 
metabolic activity is suspended to protect them from damage from chemical reactivity and 
time (Simione, 2009). The cells can then be warmed and resuscitated as needed. The thawing 
and rewarming process after the storage of oocytes and/or embryos also has a very important 
role for the survival rates (Schellander et. al, 1994). Time is the most important factor when 
warming cells. These cells are extremely fragile and need gentle handling and immediate 
settlement into a pre-warmed culture medium. Some cell types are more sensitive than others 
to the freezing process (Felipe de Lara Janz et. al, 2011). Not only do the cells need to be 
handled properly to ensure consistency and sterility but also to ensure a correct choice of type 
and amount of cryoprotective agent added (Tucker, 2007). On thawing, oocytes have to be 
rehydrated and the intracellular cryoprotectant needs to be removed. The extracellular agents, 
like sucrose, have been shown to have a beneficial influence during removal of the 
cryoprotectants (Yokoyama et. al, 2012). As explained previously,  freezing can cause cellular 
injury, resulting in cell death, especially from -15°C to -30°C (Djuwantono et. al, 2011) and cells 
will pass through this critical range twice, once during  freezing and again at thawing. 
Depending on what cryopreservation tool is used, the thawing protocol will be altered. When 
using straws, they will be immediately submerged in a 37°C water bath and then oocytes will 
be removed into a dilution solution. If on a cryolock or cryotop, the cap will be removed and 
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the stick itself will be placed into a warmed or room temperature dilution solution. Generally, 
cells should be thawed quickly to avoid ice crystal formation but diluted slowly to remove the 
intercellular cryoprotectant while preventing osmotic shock (Tucker, 2007). 
EMBRYOS 
The preservation of female genetics can be done through the preservation of the 
germplasm. Germplasm refer to the tissues maintained for the purpose of animal breeding, 
preservation, and other research uses. These resources can be animal breeding lines 
maintained in a breeding program. Gametes can be collected at different developmental 
stages using many different techniques including post ovulation flushing, transabdominal 
laparoscopic surgery, transvaginal uterine flushing, or trans rectal ovum pick up (Arav, 2014). 
These procedures may be performed during a natural estrous cycle, following chemical 
stimulation to achieve superovulation, or after fertilization at various developmental stages 
before embryo implantation. The first reports on successful embryo cryopreservation were 
published in 1971 by Whittingham (Whittingham, 1971) more than two decades after Polge 
reported success in freezing spermatozoa in 1949 (Polge and Parkes, 1949). Embryo freezing 
has the ability of preserving both parents genetic background.  In wild animals, especially with 
endangered species, this is often nearly impossible, and the opportunity to collect oocytes or 
embryos is very rare, such that researchers find it helpful to use laboratory, farm, or 
companion animals as model species during the process of developing the necessary 
reproductive techniques associated with embryo cryopreservation. According to a recent 
report by the International Embryo Transfer Society,  over 300,000 frozen thawed bovine 
embryos were transferred in 2008 worldwide (Thibier, 2009). This success was motivated by 
24 
 
three primary factors, the availability of financial resources to support an increasing number of 
studies, the availability of an unlimited flow of oocytes from slaughterhouses that make 
studies possible, and the fact that non-surgical collection of embryos is possible in cattle via 
flushing (Saragusty, 2011). Regardless of many advances in the field of embryo 
cryopreservation, there is still no agreement as to the ideal developmental stage for embryo 
cryopreservation. Factors that have an impact on fresh embryo transfer have a comparable 
effect on the transfer of frozen thawed embryos. In humans, patient age at the time of 
freezing influences pregnancy outcome due to poorer quality of oocytes collected from aged 
females, often due to aneuploidy (Sherbahn, 2011). The number of embryos transferred and 
the quality of embryos impact the outcome, in both frozen and fresh embryos (Burks et. al, 
2015). When research on human embryos is performed, the ethical questions arise whether 
we are doing research on unborn children and killing them (Beca et. al, 2014). To reduce any 
religious or moral issues the cryopreservation of oocytes was evaluated and has been shown 
to be successful.  
MATURE OOCYTES 
Maturation of the oocyte in a follicle depends on the progress of the maturation of the 
surrounding follicle cells. The oocyte is arrested for an extended time at the diplotene stage of 
the first meiosis and now will prepare itself for meiosis completion due to the triggered 
luteinizing hormone peak and the dominance of the follicle (Senger, 2005). Within the oocyte, 
the completion of the first meiosis is initiated by the ejection of the first polar body and the 
beginning of the second meiosis starts and arrests in the metaphase stage. The start of meiosis 
II is also known as the equational division (Senger, 2005). The end result is the production of 
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four haploid cells from the two haploid cells produced in meiosis one. First they go through 
prophase II, the nucleoli and nuclear envelope start to disappear, along with the shortening 
and thickening of the chromatids (Senger, 2005). Centrosomes move to the polar regions and 
arrange on the spindle fibers (Raven et. al, 2016). Centromeres attach to the spindle fibers 
from the centrosome at the opposite poles in metaphase II and will not continue until 
fertilization occurs (Raven et. al, 2016). The most characterized cytoskeletal damage by 
cryopreservation via slow cooling and vitrification concerns the disruption of sub-cortical actin 
network, microtubule depolymerization, abnormal spindle configuration and chromosome 
scattering within mature oocytes and therefore compromising the ability to develop into a 
viable embryo (Ferris et. al, 2015). One experiment, published by Huang, demonstrated that 
there is no significant difference in post-warming survival, normal spindle morphology, 
chromosome alignment and incidence of aneuploidy between in-vitro and in-vivo matured 
murine oocytes (Huang, 2008). Nonetheless, he did display that oocyte in vitro maturation and 
vitrification did decrease the cleavage and blastocyst formation rates compared to in vivo 
matured mouse oocytes after vitrification (Huang et. al, 2008). The reduced development is 
most likely an effect of an increase in DNA fragmentation occurring in the in-vitro matured 
oocytes, likely caused by suboptimal culture conditions (Huang et. al, 2008). Mature 
metaphase II mouse oocytes were divided into two groups and cryopreserved via slow freezing 
and vitrification in a study completed in early 2015. After thawing, the oocytes were observed 
for survival and fertilization, and were also compared to investigate the effect of both 
protocols on spindle reassembly and chromosome configuration at different times during 
warming. Survival rates were higher for vitrified oocytes as compared to slow frozen oocytes. 
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The morphology of the meiotic spindle was found to be in a disorganized configuration in slow 
frozen oocytes at all time points whereas in vitrified oocytes the spindles were found to be 
aligned at all-time points. Chromosomes were seen to be displaced from equatorial region in 
both groups (Jadoon, et al. 2015). This shows that vitrification may be a better protocol when 
using mature metaphase II oocytes but can the same be said to be the same with immature 
germinal vesicle oocytes?  
IMMATURE OOCYTES 
In immature oocytes the microtubules are not yet organized in the metaphase two 
spindle formations. Therefore, cryopreservation at this stage bypasses the risk of chromosome 
abnormalities as the chromatin is decondensed and is still protected by the nuclear envelope 
(Senger, 2005). Female gametes are normally cryopreserved as cumulus oocyte complexes 
(COC), with the surrounding cumulus cells which are small and numerous and are easy to 
freeze (Schellander et. al, 1994). In the late 1980s, it appeared that the oocyte was too 
vulnerable to cryopreserve at the metaphase II stage and animal work shifted to evaluating 
slow rate freezing of germinal vesicle oocytes, but little was published (Jain and Paulson, 
2006). High survival could be accomplished with mouse germinal vesicle stage oocytes (Van 
der Elst, 1992) but some studies observed reduced overall development (Schroeder et. al, 
1990), this suggested that there was no total benefit to cryopreserving at the germinal vesicle 
compared with the metaphase II stage. In many studies it has been shown that cryopreserving 
immature oocytes harms the ooplasm (Kim et. al, 2014), potentially due to inadequate 
conditions of in vitro maturation or basic oocyte defects. In a study led by Coticchio, they 
explored the possibility that the DNA of immature oocytes may be damaged and that the 
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inability to trigger a repair action is associated with the germinal vesicle arrest. They found 
double strand DNA breaks in these oocytes, and hypothesized that this may be an important 
factor affecting the meiotic resumption (Coticchio et. al, 2015). It was demonstrated that 
immature bovine oocytes are very sensitive to low temperatures from 0 to 4°C, with an 
abnormal meiotic spindle formation that inhibits the normal development of oocytes after in 
vitro fertilization (Wu and Leibo, 1999).  There are still many flaws with the experimental 
designs when using immature oocytes for patients undergoing fertility treatments. Such that, 
with current protocols it may be best to cryopreserve mature oocytes after in vitro maturation 
to metaphase II (Combelles et al. 2012). Cryopreserving after maturation to metaphase II still 
leaves us with the issue of the spindle fibers being damaged during cryopreservation by ice 
crystal formation. Oocyte freezing is more advisable for patients with personal, moral, or 
religious objections to the cryopreservation of embryos as oocyte cryopreservation would 
eliminate many of these ethical and legal implications. It is much more acceptable to discard 
frozen oocytes rather than frozen embryos.  
IN VITRO EMBRYO PRODUCTION 
In vitro maturation and in vitro fertilization are both steps in the in vitro embryo 
production process. In vitro maturation is a precursor to in vitro fertilization when using 
immature oocytes. In vitro maturation is an optional step depending on the state of the 
oocytes at retrieval: with in vitro fertilization, the oocytes are normally matured inside the 
ovaries, while in in vitro maturation the immature oocytes are removed and then are matured 
outside the body. In vitro maturation requires no hyper stimulation of the ovaries. Once the 
immature oocytes are removed, they are placed in a petri dish and exposed to a combination 
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of luteinizing hormones and follicle stimulating hormones. The oocytes are usually left in this 
medium for 22 to 24 hours; once they have reached maturation, they are then inseminated 
normally (by IVF) or by intracytoplasmic sperm injection (ICSI) for fertilization of the matured 
oocytes (Lim et. al, 2013). The developing embryos are then transferred back into the uterus 
within four to seven days. While the success rates for in vitro maturation are better than in the 
past, they are still lower than those for in vitro fertilization following in vivo maturation. 
Pregnancy rates differ based on a few factors, the most important being the age of the 
females’ oocytes (Sherbahn, 2011). In humans, a typical 35-year-old woman, with no major 
health problems, can normally have a 40% success rate for a single cycle of in vitro fertilization, 
compared to 32% with in vitro maturation (Abma et. al, 1997). A full cycle of in vitro 
fertilization can cost as much as $30,000, while a full cycle of in vitro maturation is closer to 
$6,000 and often both procedures need to be repeated before pregnancy occurs (Abma et. al, 
1997). In vitro maturation is clearly a safer alternative than using in vivo matured oocytes for 
in vitro fertilization in patients’ sensitive to gonadotropins. In vitro maturation may be the 
procedure of choice not only for infertile couples but also for obtaining oocytes for 
preservation of fertility. In vitro maturation is a good alternative in fertilization preservation in 
cancer patients. The process of in vitro maturation can be conducted safely even with patients 
who are hormone sensitive. In vitro maturation could be a key method used for patients who 
are soon to be using cancer therapy since there is no interruption to treatment for ovarian 
stimulation (Lim et. al, 2013). 
In vitro fertilization is the combination of an oocyte with a sperm cell in a petri dish to 
achieve successful fertilization. In vitro fertilization is a common assisted reproductive 
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technology, the first successful in vitro fertilization and birth of live offspring using frozen 
thawed mouse oocytes was reported in 1976 (Parkening and Chang, 1976). The process of in 
vitro fertilization is very basic; often beginning with super ovulation of the female to obtain 
mature oocytes. This can be done with hormonal injections; follicle stimulating hormone, 
luteinizing hormone, prostaglandin and others (Yenkie and Diwekar, 2014). Super ovulation 
helps the female mature more than one oocyte in a cycle to optimize retrieval rates.  
The second step is harvesting the oocytes which can be done through multiple 
methods; surgically exposing the ovary and aspirating the follicles, non-surgically aspirating the 
follicles utilizing ultrasonography and a hypodermic needle, and aspirating follicles 
postmortem (Lai et. al, 2015). The most common technique for recovery of oocytes by 
aspiration in equids involves inserting a needle through the vaginal wall and the use of an 
ultrasound. This helps identify the dominant follicles before aspirating the oocytes into a 
special apparatus, such as a filter (Ulloa et. al, 2015). With humans it is done through a minor 
surgery of inserting a thin needle through the vagina and into the ovary and follicles that 
contain the oocytes. This needle is connected to a suction device which then pulls the oocytes 
and the fluid out of each follicle, one at a time (Ulloa et. al, 2015). The procedure with bovine 
is very similar, it is done the same way but investigators go rectally to grasp the ovary and then 
go in vaginally with the ultrasound and follicle aspirator to remove the oocytes from the 
ovaries (Ulloa et. al, 2015).  
The next step is insemination and fertilization; sperm cells that have good motility and 
morphology are selected and then placed with the best quality oocytes. To isolate the best 
quality bovine sperm cells they are put into a percoll gradient and centrifuged down multiple 
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times. There is two-layer density gradient which separates the motile and non-motile sperm 
cells. The fast and well moving sperm cells will be able to swim down through the lower 
gradient, but the poor cells will be trapped in the gradient interface (Guimaraes et. al, 2014). 
To determine the best quality oocytes, the amount of cumulus cell layers is evaluated. More 
layers of cumulus present are associated with increased transfer of necessary factors to the 
oocytes to fertilize and grow throughout the in vitro fertilization process (Tetsuka et. al, 2015).  
The fourth step consists of monitoring the embryo, to make sure it is growing properly. 
The embryo will be dividing rapidly at this time and by day seven the embryo will be ready for 
transfer (Moreno et. al, 2015). To transfer an embryo a catheter containing the embryos is 
inserted into the vagina, through the cervix, and up into the uterus. Pregnancy occurs and is 
successful if an embryo sticks and is implanted in the lining of the uterus and grows (Moreno 
et. al, 2015). Choosing embryos with the highest developmental potential is one key step to 
overcoming the hurdle of early embryonic mortality. The success of the development of the 
embryo is highly complex and depends on both the embryo quality and the maternal 
receptivity. (Tanabe and Hasler, 1985) Oocyte quality is another important factor to the health 
of the embryo (Dumesic, 2015). Regardless of these factors, the survival depends on the 
delicate placement of the embryos at the proper location. The first successful embryo transfer 
was done in a rabbit in 1890 by Walter Heape (1890), and began in food animals in the 1930s 
with sheep and goats (Warwick and Horlacher, 1934) and later in cattle (Chang, 1951) and 
swine (Day and Melampy, 1959) in the 1950s. Commercial and non-invasive embryo transfers 
in the United States began in the early 1970s and continues to thrive (Moffit, 1979). Pregnancy 
rates are generally around 60% with fresh embryo transfer and 50-60% with frozen thawed 
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embryo transfers (Galliano et. al, 2015). In cattle there are about 150,000 potential oocytes 
(Selk, 2016) in the female but in natural breeding only a fraction of the reproductive potential 
of a single cow can be realized. Embryo transfer is a technique that can greatly increase the 
number of offspring that a genetically superior cow can produce.   
CURRENT ISSUES FOR FUTURE RESEARCH 
  The global diversity of domestic animals is considered to be under threat, a large 
number of domestic animals worldwide are endangered or in critical status. In farm animals, 
trends in within-breed diversity are as significant as between-breed diversity that are in 
demand to be able to manage with changing requirements. These would include the 
requirements in breeding and the selection process. Cryopreservation of germplasm is a smart 
strategy to conserve existing diversity for future use commercially and in rare breeds. There 
are studies (Baka et. al, 1995) (Combelles and Chateau, 2012) (Fasano et. l, 2014) that not only 
affect our domestic and wild species but humans as well. Although over one hundred babies 
have been born from oocyte storage, pregnancy rates still remain low (Cobo et. al, 2015). 
Others problems beyond intracellular ice formation and osmotic effects need to be identified. 
The ability to cryopreserve human oocytes and store them would be beneficial for cancer 
patients, since there is a risk of these patients becoming sterile after therapy (Barcroft et. al, 
2013). It would also be beneficial for women who want to delay reproduction and to alleviate 
religious concerns dealing with embryo storage. Studying and experimenting with domestic 




New methods that include vitrification have proven useful in increasing the survival and 
pregnancy rates of oocytes and embryos. There are other methods that have not been tested 
yet, including different protocols, processes and solutions, cryoprotectant concentrations and 
others with both immature and mature oocytes. The study and research of vitrification 
protocols has led to the formation of new ideas and has demonstrated the flexibility of cells to 
survive cryopreservation.  In general, further advances are needed to improve the storage of 
human oocytes before a widespread routine is used in clinics worldwide. The use of animal 
oocytes and embryo will help resolve these issues and find an optimal cryopreservation 



































In vitro production can be maximized through the use of cryopreservation for long term 
oocyte storage (Shaw 2000). Cryopreserving of mature oocytes can result in damage to the 
metaphase spindle due to the temperature sensitivity of the microfilaments and microtubules 
as well as other morphological issues (Baka et. al, 1995). In 2008 Huang observed a decrease in 
cleavage and blastocyst formation of murine IVM oocytes after vitrification compared to in 
vivo oocytes (Huang et. al, 2008). In addition, Jadoon and others concluded the meiotic spindle 
of mature metaphase II mouse oocytes after cryopreservation were disorganized and 
displaced (Jadoon, et al. 2015). Cryopreservation of immature oocytes may circumvent this 
problem because these structures have not yet formed and the genetic material is enclosed 
within a nuclear envelope (Benson, 2008). However, Kim demonstrated that cryopreserving 
immature rat oocytes may harm the ooplam leading to reduced development and compromise 
cell cycle status compared to fresh control oocytes (Kim et. al, 2014).  The use of different 
cryoprotectants can also affect the viability of each specific cell type for the freezing and 
warming process. DMSO and glycerol are the most commonly used cryoprotectants but have 
mixed results of specific cell types and sizes. Si and colleagues found that glycerol at 
concentrations below 5% in comparison to 15% dimethyl sulfoxide led to improved post-thaw 
survival (Si, 2004). However, Lim and colleagues showed that IVM bovine oocytes were more 
morphologically normal, had higher spermatozoa penetration rate and higher percentage 
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developed to 2-cell stage at 48 h postinsemination when cryopreserved with 1.0 M DMSO 
versus 1.0 M glycerol (Lim et. al, 1999)  
The aim of these experiments was to determine if immature and mature cumulus cell 
complexes cryopreserved via vitrification with dimethyl sulfoxide and glycerol solutions would 
remain viable following thawing and in vitro fertilization, as indicated by pronuclei formation. 
The specific aim was to vitrify immature germinal vesicle stage COC in different 
cryoprotectants to determine differences in survival, as assessed through post thaw oocyte 
maturation and fertilization rates with mature oocytes after in vitro fertilization. The second 
aim was to vitrify mature M2 stage COC in different cryoprotectants with an endpoint 
including post thaw oocyte fertilization rates in mature oocytes after in vitro fertilization. We 
hypothesized that DMSO would yield higher survival and fertilization rates than glycerol for 
both immature and mature bovine oocytes. We also hypothesized that immature bovine 
oocytes would fertilize at a higher rate than mature oocytes after vitrification and IVF. 
An experiment conducted in 2013 determined if immature oocytes cryopreserved by 
vitrification and slow rate freezing would resume meiosis upon thawing (Hardin et. al, 2013). 
There were two separate experiments in this study, comparing vitrification and slow rate to 
one another with controls. Within the first experiment oocytes were cryopreserved via slow 
rate freezing process using 10% ethylene glycol. The second experiment was subjected to 
vitrification in a three step process using glycerol and ethylene glycol (10% glycerol for 5 
minutes, 10% glycerol and 20% ethylene glycol for 5 minutes then 24% glycerol and 26% 
ethylene glycol for 45 seconds). Upon thawing and IVM the results in the slow rate freezing 
group yielded oocytes matured to the metaphase two stage at the same rate as the controls 
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(45% and 55% respectively P = 0.44). Within the vitrification group the cryopreserved oocytes 
matured to the metaphase two stage at a lower rate than the controls (49% and 79% P = 0.01). 
This experiment indicated that immature cryopreserved oocytes would resume meiosis 
following warming while vitrified immature oocytes matured at a lower rate than controls 
under these conditions. These unexpected results gave us motivation to further investigate 
vitrification on immature bovine oocytes.  
MATERIALS AND METHODS  
Unless otherwise stated, all chemicals were obtained from Sigma-Aldrich Chemical Co. 
(St. Louis, MO, USA).  
EXPERIMENTAL DESIGN  
 Oocytes from Angus cross cows located in St. Gabriel, LA at the LSU Reproductive 
Biology Center were collected by transvaginal ultrasound-guided follicular aspiration (TUGA) 
and vitrified immediately as immature oocytes (experiment one). On a separate collection day 
oocytes were placed into maturation immediately after OPU and prior to manipulation 
(experiment two). A total of 200 mature oocytes and 200 immature oocytes were collected 
and vitrified in DMSO and glycerol treatment groups in both experiments.  
EXPERIMENT ONE DESIGN 
Oocytes were vitrified using two cryoprotectants solutions on cryolocks immediately 
after collection and stored in liquid nitrogen for at least seven days (Table 3.1). After 
vitrification and storage, oocytes were thawed in the dilution solution for 5 minutes (Table 
3.4), washed with HEPES-TALP and placed in 40 µL droplets of standard IVM medium 
consisting of M199 supplemented with 10% fetal bovine serum (FBS), 0.2 mM sodium 
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pyruvate, 1% pen/strep, 2 mM glutamine, and FSH (5.0 μg/mL) (Appendix B) covered with 
mineral oil. Following maturation for 22 hours within the 5% CO2 incubator, 10% of the 
oocytes were evaluated for maturation rate by fixation in 3:1 methanol acetic acid for at least 
48 hours and stained with aceto orcein. The remaining oocytes were placed into standard IVF 
for fertilization for 18 hours in a 5% CO2 incubator. After 18 hours they were vortexed in 1 
mg/mL hyaluronidase solution and put into global 35+ droplets covered with oil and cultured 
for 24 hours. They were then stained with Hoechst 33342 and evaluated to determine their 
pronuclei formation, then fixed and stained in acetic orcein for further evaluation. 
EXPERIMENT TWO DESIGN  
Aspirated oocytes were put into 40 µL droplets of standard IVM medium covered with 
mineral oil immediately after collection and prior to vitrification in 5% CO2 incubator for 22 
hours. Following maturation, 10% of the oocytes were evaluated to determine maturation rate 
by fixation in 3:1 methanol acetic acid for at least 48 hours and staining with aceto Orcein 
(Appendix A and B). The remaining oocytes were then vitrified using DMSO and Glycerol 
cryoprotectant solutions, shown in table 3.1 (5 minutes in the first solution and 45 seconds in 
the second solution) (Appendix A and B) on cryolocks and stored in liquid nitrogen for at least 
seven days. After vitrification and storage, all oocytes in both cryoprotectant groups were 
thawed in an 0.025M sucrose dilution solution shown in table 3.2 for 5 minutes and washed 
with HEPES-TALP (Appendix B). Oocytes were then placed into standard IVF (see Appendix A 
and B) for fertilization in 5% CO2 incubator for 18 hours. After 18 hours they were then 
vortexed in 1 mg/mL hyaluronidase solution (Appendix B) and put into global 35+, embryos 
culture media (Life Global) droplets covered with oil for 24 hours. They were then stained and 
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evaluated using Hoechst 33342 (Appendix A and B) to determine pronuclear formation and 
then fixed to be stained in acetic orcein for further evaluation.   
Table 3.1 Composition of Cryoprotectant Solutions for both Treatments  
Vitrification Solutions for Glycerol Treatment Vitrification Solutions for DMSO Treatment 
Vitrification One  Vitrification Two  Vitrification One  Vitrification Two  
PBS PBS PBS  PBS  
20% Calf Serum 20% Calf Serum 20% Calf Serum  20% Calf Serum  
10% Ethylene Glycol 20% Ethylene Glycol 10% Ethylene Glycol 20% Ethylene Glycol 
10% Glycerol  20% Glycerol  10% DMSO 20% DMSO  
0.5 M sucrose  0.5 M sucrose  0.5 M sucrose  0.5 M sucrose  
 





IVF VALIDATION  
As validation of the IVF system, we received matured oocytes from a commercial 
source DeSoto Biosciences (TN). Oocytes went into IVF-TALP (Appendix A and B) 20-30 per well 
with percoll separated sperm cells and incubated in 5% CO2 for 18 hours. After 18 hours they 
were vortexed in hyaluronidase and put into 50 µL droplets of global 35+ medium covered in 
oil until the next morning. All oocytes were then stained and evaluated using Hoechst 33342 to 
PBS 16 mL 
20% Calf Serum 4 mL 
0.025 M Sucrose 0.855g 
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determine pronuclei formation and then fixed and stained in acetic orcein for further 
evaluation.  
PREPARATION  
 Required media included Dulbecco’s Phosphate Buffered Saline (D-PBS), Hepes TALP, 
standard maturation medium, dimethyl sulfoxide vitrification solution, glycerol vitrification 
solution, dilution solution, standard fertilization medium and culture medium (Appendix B) 
was prepared the day prior to use. On the afternoon before oocyte collection, D-PBS was 
placed in the incubator to warm overnight. 10 mL of bovine calf serum (BCS) and 1 mL of 
Heparin (Sagent Pharmaceuticals, Schaumburg, IL, USA) were added to the D-PBS the morning 
of collection. HEPES-TALP holding media for the control and treatment groups consisted of 20 
mL HEPES-TL (Caisson Labs, North Logan, UT, USA) with 60 mg BSA and 200 μL sodium 
pyruvate and pen/strep (Gibco, No.15140). 
  On the afternoon before oocyte collection, all necessary media dishes were prepared 
with premade solutions and equilibrated for at least two hours in the incubator before being 
used. Petri dishes (35mm, BD Falcon) of HEPES-TALP and D-PBS were placed in a non-CO2 
incubator at 39ᵒC to warm 2 hours prior to oocyte collection, for washing, and sorting into 
treatment groups. 500 µL of fertilization media was put into a 4 well dish and water put into 
the center on the dish. Both maturation and fertilization media were then placed into a 37°C 
5% CO2 incubator for at least 2 hours prior to adding oocytes, to allow for equilibration. 
Fixation media was a 3:1 solution of methanol acetic acid and was added before staining in 




OOCYTE COLLECTION  
These experiments consisted of 9 collection days, four for experiment one and five for 
experiment two. Oocytes were collected from follicles three to eight mm in diameter by 
transvaginal ultrasound-guided follicular aspiration. Oocytes from all aspirations on a given day 
were pooled and transferred to a 35 mm dish containing pre-warmed HEPES-TALP holding 
medium.  Oocytes were randomly assigned to one of the two treatment groups: dimethyl 
sulfoxide or glycerol cryoprotectant solution.  Each collection day was pre-determined to be an 
immature or mature oocyte group. Following collection oocytes were either matured or 
vitrified following above outlined procedures in accordance with the allocated groups for that 
specific day.  
TRANSVAGINAL ULTRASOUND-GUIDED FOLLICULAR ASPIRATION  
Oocytes were obtained with TUGA (Figure 3.1) at the LSU AgCenter, Reproductive 
Biology Center in St. Gabriel, LA.  Each cow was held within a holding chute and given an 
epidural injection of 5 mL lidocaine (Vet One, Product No. 510212) between vertebrae near 
the base of the tail.  An ultrasound probe with a 7.5 MHz transducer was inserted into the 
vaginal canal, and the ovary was held through the rectum and placed against the vaginal wall 
along the transducer at the end of the ultrasound probe. The ovary was observed on an 
ultrasound monitor and the follicles were identified. An 18-gauge disposable collection needle 
inside the ultrasound probe was connected to a suction pump via polyethylene tubing, after 
good visualization of the follicle with the ultrasound, the collection needle was advanced 
through the vaginal wall and into the follicle, the follicular fluid along with the oocytes were 
aspirated via suction. The tubing and needles were rinsed with collection media after each 
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ovary and the needle changed after each cow, the follicular fluid and oocytes were deposited 
into an embryo collection filter (Agtech Inc., Manhattan, KS, USA).  All media were maintained 
at 39°C during collection with a heated tube holder. After collection of two cows the tubing 
and needles were rinsed with collection media (D-PBS with heparin and BCS) and all fluid 
filtered and poured into a search dish. Oocytes were located and placed into a warmed 35 mm 
dish containing HEPES-TALP. 
Following collection, all oocytes were then placed into a 1mL micro centrifuge tube 
containing warmed HEPES-TALP and transferred to the Animal and Food Science Laboratory on 









VITRIFICATION AND WARMING PROCEDURES  
Oocytes in both maturation groups were vitrified in both dimethyl sulfoxide and 
glycerol cryoprotectant groups. Oocytes, within each day were randomly assigned to glycerol 
or DMSO group for vitrification. Groups of two to five oocytes would be placed into the 
designated equilibration solution for 5 minutes (Figure 3.2). They were then transferred to the 
Figure 3.1 Diagram of transvaginal ultrasound-guided follicular aspiration. (Drawing 
by E. Meintjes, 1995) 
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higher concentration vitrification solution, placed on the cryolock device (Figure 3.3), excess 
media removed and plunged into liquid nitrogen within 45 seconds (Figure 3.2). The tops to 
the cryolocks were put on with forceps after being plunged into liquid nitrogen. The immature 
group of oocytes would go through the same procedure without maturation beforehand. They 
were transferred to the Food and Animal Science Laboratory Building in HEPES-TALP and 
vitrified immediately.  
After the oocytes were stored in the liquid nitrogen for at least seven days, the 
cryolocks were removed from the canisters, the tops removed and the vitrified oocytes on the 
cryolocks were immersed directly into a petri dish containing the warmed dilution solution and 
were kept there for 5 minutes to insure all cryoprotectants were removed from the ooplasm. 
Oocytes that had been thawed were then rinsed in HEPES-TALP.  Matured oocytes were then 
washed in IVF-TALP and then placed into 48 µL droplets of IVF-TALP. The oocytes were in 
groups of 10-12 per droplet, in a 35mm dish that was being held within the 5% CO2 incubator 





















IN VITRO FERTILIZATION  
 In vitro fertilization was performed using spermatozoa from multiple batches of semen 
from a single Angus bull of proven fertility that had been frozen in straws, from Genex. One 
Figure 3.2 Cryolock vitrification and warming procedure for both experiments. 
Figure 3.3 One denuded bovine oocyte loaded onto Cryolock device (indicated by arrow) 
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0.25 mL straw of frozen semen was thawed in a 39°C water bath for 30 seconds.  Semen was 
separated on percoll gradient (Irvine Scientific 99264) and washed three times using IVF- TALP 
by centrifugation at 400 x g for 20 minutes starting at 37°C and reducing to 25°C, 10 minutes 
and 5 minutes consecutively. Each time the sperm pellet was re-suspended with a reducing 
amount of IVF-TALP.  After the last suspension, the IVF-TALP was aspirated down to the sperm 
pellet and the appropriate amount of IVF-TALP was added to reach a final concentration of 1 x 
10^6 sperm/mL. 20 µL of the final sperm suspension was added to each well of oocytes and 
IVF-TALP within a 5% CO2 incubator at 39°C for 18 hours. 
Example: 7500/X = µL of sperm; 300- µL of sperm = amount of IVF-TALP 
Sperm morphology was evaluated by adding 95 µL of water to 5 µL of the sperm pellet 
to a micro centrifuge tube and gently mixing. 10 µL of sperm dilution was added to each side 
of the hemocytometer and sperm was counted. Sperm mobility was also estimated post thaw, 
by looking under a microscope. 
STAINING AND DATA COLLECTION  
All oocytes were placed into Hoechst 33342 (5 µL with 500 µL HEPES) for 10 minutes. 
They were then rinsed in HEPES-TALP and 8-10 embryos were transferred to a microscope 
slide with minimal media, and mounted on the slide with a cover slip. They were observed 
with an epi-fluorescent microscope equipped with UV excitation and appropriate barrier filters 
using Hoechst 33342, 42 hours after IVF.   
STATISTICAL ANALYSIS  
This experiment consisted of 9 replicates, 5 mature oocyte groups and 4 immature 
oocyte groups. Assessment of oocyte viability was based on morphology, the fertilization rate 
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as indicated by cleavage, and development rate was compared within respective parameters 
using Fisher Exact Test. Means with a probability value of P< 0.05 were considered significantly 
different. 
RESULTS   
EXPERIMENT ONE 
 IVF results of immature oocytes after vitrification in the DMSO treatment group had 
8.49% fertilization rate compared with 0% oocytes in the glycerol group, seen in Table 3.3. 
There was no statistical difference between DMSO and glycerol fertilized oocytes with the P-
value of P= 0.0056 due to low numbers of oocytes fertilized (DMSO 9/106).  The results for 
both treatment groups did show a proportion of the oocytes having polyspermy fertilization 
(3.77% and 3.70%).  
ᴬ Oocytes matured includes oocytes fertilized  
*Proportions with a probability value of P<0.05 were considered significantly different 
 DMSO % (no.) Glycerol % (no.) P value 
Matured ᴬ 12.26% (13/106) 2.47% (2/81) 0.0149 
Fertilized 8.49% (9/106) 0%  0.0056 
Immature 0% 1.23% (1/81) 0.4332 














Results also demonstrated that some proportion of oocytes became matured (12.26% 
and 2.47%) after vitrification in both treatment groups and showed a significant difference the 
two (P=0.0149) but were not able to become fertilized. Results also show a small proportion of 
oocytes still immature (1.23% Glycerol) after vitrification, IVM and IVF, signifying that 
vitrification could be interfering with the resumption of meiosis. The majority amount of the 
oocytes was degenerate (74.04% DMSO 80.49% glycerol) and some were indeterminate 
(11.54% DMSO 7.32% glycerol) (as described in oocyte analysis). The numbers, proportions 
and P-values can be seen in Table 3.3. Pictures taken after Hoechst 33342 and Acetic Orcein 
staining can be seen in Figure 3.4 of both treatments groups within the first experiment 
illustrating different nuclear maturation observed after IVF.  





Oocytes were analyzed (Table 3.3), for nuclear status and development following 
fertilization, pictures as followed in Figure 3.4. The indication of fertilization included 
formation of two pronuclei. Matured oocytes had either one pronucleus, a metaphase two 
plate or were anaphase stage (detailed tables found in Appendix C). Immature group indicated 
oocytes in metaphase one, and polyspermy means polyspermy fertilization occurred. The 
degenerate variable means that the oocytes were dead. The indeterminate variable means 
that the oocytes were unknown, had sperm heads and/or cumulus cells interfering with 
visualization (detailed tables found in Appendix C).  
EXPERIMENT TWO 
Mature oocytes had fertilization in both cryoprotectant treatment groups after 
vitrification and IVF, but with low proportions in both treatments, DMSO 12.62% fertilized and 
glycerol 3.4% seen in Table 3.4. There is a statistically significant difference between the two 
cryoprotectants with a P-value of 0.0335. The results for the glycerol treatment group did 
show a proportion of the oocytes having polyspermy fertilization (3.4%) but none in the DMSO 
group. The results also revealed that a decent portion of oocytes were still mature after IVF in 
both treatments (29.12% DMSO and 13.63% glycerol) and showed a significant difference 
(P=0.0136). There were also some oocytes that did not mature after IVM and prior to 
vitrification that were designated as immature oocytes. The majority of the oocytes were 
degenerate or indeterminate (as described in oocyte analysis). Pictures taken after Hoechst 
33342 and Acetic Orcein staining can be seen in Figure 3.5 with treatments groups within the 
second experiment illustrating different nuclear maturation observed after IVF. 
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Oocytes were analyzed (Table 3.4), for nuclear status and development following 
fertilization. The indication of fertilization included formation of two pronuclei and included 
three cell and four cell embryo development as seen in Figure 3.5. Matured oocytes had either 
one pronucleus, a metaphase two plate or were anaphase stage (detailed tables found in 
Appendix C). Immature group indicated oocytes in metaphase one or germinal vesicles being 
present, and polyspermy means polyspermy fertilization occurred. The degenerate variable 
means that the oocytes were dead. The indeterminate variable means that the oocytes were 








ᴬOocytes matured includes oocytes fertilized  




 DMSO % (no.) Glycerol % (no.) P value 
Matured ᴬ 29.12% (30/103) 13.63% (12/88) 0.0136 
Fertilized  12.62% (13/103) 3.41% (3/88) 0.0335 
Immature 4.85% (5/103) 1.14% (1/88) 0.2201 




























IVF VALIDATION RESULTS 
To validate IVF procedure, in vitro fertilization procedure was done with matured 
cumulus cell complexed bovine oocytes from a commercial source for the sole purpose of 
validating IVF. 63.88% were fertilized (46/72). In conclusion our IVF methods could be utilized 
to analyze the pronuclear formation with bovine cumulus cell complex oocytes. 
MATURATION CHECK  
Maturation rate was evaluated in a subset of oocytes from each group, in the first 
experiment maturation was evaluated after IVM and vitrification. The first experiment, 
immature oocytes showed that 2/10 oocytes advanced to metaphase two stage in the glycerol 





treatment group, 4 were lost or crushed and 4 were immature. Within in the DMSO treatment 
group 3/10 showed metaphase one maturation, 2 exhibited germinal vesicles and 1 confirmed 
germinal vesicle breakdown, and 3 were degenerate. Therefore 20% showed maturation prior 
to IVF in the immature glycerol group and 30% showed maturation prior to IVF in the 
immature DMSO group.   
In experiment two after IVM and prior to vitrification 61.5% attained a metaphase two 
plate indicating maturation. After vitrification and warming of matured oocytes in the second 
experiment maturation in both cryoprotective groups was evaluated prior to IVF and 0% 
showed a metaphase two plate, all were degenerate regardless of treatment.  
DISCUSSION  
The aim of these experiments was to determine if immature and mature cumulus cell 
oocyte complexes cryopreserved via vitrification with dimethyl sulfoxide or glycerol solutions 
would illustrate pronuclear formation following warming and in vitro fertilization, indicating 
viability. Discovering an optimal vitrification, warming, IVF, and culture procedure for bovine 
immature and mature cumulus cell complexes would be beneficial for infertility issues and 
improving gene pools.  Within these experiments we made some progress towards optimizing 
the conditions of vitrification with bovine oocytes.  
In the first experiment, fertilization occurred within the DMSO treatment group but not 
the glycerol treatment group, however, there was statistically significant difference (P=0.0056) 
between treatment groups, due to the proportions of oocytes in DMSO treatment group being 
fertilized (Table 3.3). The low fertilization rates in the first experiment could be affected by the 
maturation rate of the oocytes. After vitrification the oocytes most likely did not mature 
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properly or were morphologically altered leading to the low fertilization rates (8.49% DMSO) 
but the high number of oocytes that were still in the metaphase two stage (12.26% DMSO 
2.47% glycerol) could indicate issues with the formation of metaphase plates after vitrification 
and upon warming and IVM. These results showed a significant difference between DMSO and 
glycerol (P=0.0149) suggesting that DMSO cryoprotectant is significantly superior for 
cryopreservation followed by maturation of oocytes when combined with ethylene glycol. 
Specifically, a possible interruption of the tubulin formation. The spindle apparatus is a 
dynamic conglomerate of microtubules and associated structural proteins, acting to 
coordinate cytokinetic and karyokinetic events essential for normal chromosome segregation 
(Jung, 2014). First meiotic division is completed by cooperation of cytoskeletons, especially 
microfilaments and microtubules. The cytoskeleton is a key factor to successful competent 
oocytes. Matured oocytes stay in metaphase block until the entry of spermatozoa (Pickering, 
1987). This block is accomplished by stable spindle and other regulators for cell cycle. As 
oocytes transit into metaphase, microtubules change from radial arrays to an organized barrel 
shaped structure containing dense material at either pole known as microtubules organizing 
centers (MTOCs) (Aman, 1994). The polyspermic fertilization in the first experiment 
(3.77%DMSO, 3.70% glycerol) may indicate a possibility that vitrification of oocytes is affecting 
the zona pellucida’s ability to become hardened after fertilization possibly disrupting the 
cortical granule reaction. The cortical reaction is a process initiated during fertilization by the 
release of cortical granules from the oocyte which prevents polyspermic fertilization. In 
contrast to the fast block of polyspermy which immediately but temporarily blocks additional 
sperm from fertilizing the oocyte, the cortical reaction gradually establishes a permanent 
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barrier. Another hypothesis is that the cryoprotectants are not penetrating the cell membrane 
creating osmotic stress on the oocytes and ice crystals are forming. These ice crystals can 
puncture holes through the cell membrane allowing multiple spermatozoa to enter the 
oocytes cytoplasm and causing polyspermic fertilization. If the spermatozoa are not 
penetrating the membrane and entering through possible holes formed by ice crystals then 
oocyte activation is not occurring, producing multiple sperm pronuclei but not the maternal 
pronucleus. Polyspermic fertilization of oocytes could also be affecting the intracellular 
calcium concentration resulting in an elevation after cryopreservation, which could trigger 
cortical granule release and cause premature hardening of the zona pellucida and 
parthenogenetic activation. These results can be compared to the fact that our controls had no 
sign of polyspermic fertilization. There was also a trend of degeneration in experiment one 
that points to an influence of deleterious trends of vitrification and possibly from the 
cryoprotectants used that effect the immature oocytes ability to become matured and/or 
affect the oocytes that did become mature to become fertilized. 
In the second experiment we saw a statistically significant difference between 
treatments of DMSO and glycerol when looking at the fertilization rate after IVF, DMSO being 
12.5% fertilized (13/103) and glycerol being 3.4% fertilized (3/88) with a P value of 0.0335 
indicating a significant difference between the two cryoprotectants. These results indicate that 
both combinations of cryoprotective agents in vitrification can be used successfully for both 
mature bovine oocyte cumulus cell complexes but that DMSO cryoprotectant may be a more 
suitable agent for matured bovine oocytes. A large portion of oocytes remained in the 
metaphase two stage (29.12% DMSO 13.63% glycerol) with a P value of 0.0136 after IVF 
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leading us to believe that vitrification is affecting the viability and altering the oocytes prior to 
IVF. These results also suggest that DMSO cryoprotectant is more ideal for recovering the 
metaphase plate of oocytes after cryopreservation. It has been well documented that oocytes 
suffer from reversible and irreversible damage during cryopreservation. This damage includes 
hardening of the zona pellucida, premature cortical granules release, depolymerization of the 
microtubules, and misalignment of the chromosomes. Vitrification has in the past negatively 
affected spindle morphology and other organelle morphology in mature oocytes (Purohit, 
2012) and could possibly be affecting mature oocytes after vitrification in this experiment as 
well. Importantly, the mechanism of meiotic spindle regeneration after oocyte 
cryopreservation is essentially unknown (Ma, 2010) In Table 3.3 and Figure 3.5 there were 
oocytes showing maturation after IVF indicating that spindle repair occurred but fertilization 
could not, possibly be effecting the tubulin or pre-hardening of the zona pellucida. Studies 
with mice demonstrated that cryopreservation induced hardening of the zona pellucida and 
premature release of the cortical granule content (Al- Hasani, 1987, Gook, 1993) inhibiting 
sperm penetration and fertilization. During the freezing process, fracture of the zona pellucida 
and ooplasmic membrane disruption could also occur. In a past experiment taxol was used to 
help re-polymerize disrupted microtubules of somatic cells (Jordan et al. 1993) and oocytes 
(Morato et al. 2008) and is a cytoskeleton stabilizer. Taxol has been shown to improve 
vitrification of human immature oocytes and bovine, ovine and murine mature oocytes (Shi et 
al. 2006, Morato et al. 2008, and Zhang, 2009) Cytochalasin B is also a cytoskeletal stabilizer 
and has also been suggested to improve post- thaw development of mouse and porcine 
oocytes (Park, 2001, Dobrinsky, 2000). There was also a trend of degeneration in experiment 
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two that points to an influence of deleterious trends of vitrification and possibly from the 
cryoprotectants used that effect the mature oocytes ability to repair the metaphase spindles 
or other organelle disruption or can affect the matured oocytes after vitrification to become 
fertilized. 
In both experiments during warming, the dilution solution consisted of PBS, calf serum, 
and sucrose. Vitrified oocytes are sensitive to osmotic changes during warming. Many studies 
have a warming procedure in a series of steps, starting at a high concentration of an 
extracellular agent like sucrose and reduce it over a short period of time. In the book titled 
Human Assisted Reproductive Technology, Gardner explains that warming human embryos 
first go into a sucrose solution of 0.65M for 30seconds, then into 0.325M sucrose for 1 minute, 
0.125M sucrose for 2 minutes then 0.0M sucrose for 5 minutes. The results yielded a 92.1% 
cryosurvival rate (Gardner, 2011).  As early as in 1993, mouse embryos were vitrified with 
2.75 M dimethyl sulfoxide and 2.75 M propylene glycol supplemented with 1.0 M sucrose after 
30 second exposure, which revealed a significantly higher in vitro survival rate of 82% than the 
solution without 1.0 M sucrose, 44% (Tada, 1993). Additionally, it has been reported that 
vitrification solution with sugars could improve the survival rate of the vitrified bovine 
blastocysts (Saito, 1994). In another study the use of sucrose in the warming solutions had no 
significant effect on expansion or hatching rates on vitrified mouse embryos, results yielded 
76-82% with 0.0M sucrose compared to 40-54% with 0.8M sucrose. It was concluded that 
vitrification solutions should contain a moderate concentrations of sucrose, however in 
dilution medium sucrose is unnecessary (Al Yacoub, 2013). In the two experiments of this 
thesis the warming solution consisted of 0.025M sucrose and oocytes were washed for 5 
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minutes. Originally the protocol called for 0.5M sucrose for the vitrification solutions and the 
dilution solution, however the warming solution contained a reduced amount of sucrose to 
observe the cryosurvival of a lower concentration. In reported studies it has been 
demonstrated that a high concentration of sucrose is not needed for warming solution after 
vitrification and a lower amount has beneficial factors on cryosurvival (Al Yacoub, 2013). The 
results in the present study had a low survival rate in both experiments indicating that there 
could be a possibility of reduced cryosurvival with the vitrification process or the warming 
process. This could be a possible future experiment, comparing a low sucrose concentration 
with a higher sucrose level in the warming solution and in the vitrification solutions to see 
possible morphology changes.  
There were trends that focused our attention to the cryoprotectant DMSO showing 
more promising results in fertilization rates in both experiments, 8.49% fertilization in DMSO 
to 0% in glycerol and 12.62% in DMSO and 3.4% in glycerol in the second experiment. We 
cannot say that there was a statically significant difference between the two experiments, but 
what we observed we can say that dimethyl sulfoxide may have a better potential in 
vitrification of both immature and mature bovine oocyte and bears further investigation. 
Previous studies demonstrated the beneficial effect of DMSO in spindle polymerization 
(Kuleshova, 1999). Therefore, the use of DMSO for oocyte cryopreservation might have a 
protective effect during vitrification (Kuleshova, 1999, Katayama, 2003) These results provide 
the opportunity to explore other variables with optimizing the vitrification procedure or 
protocol for a particular cell type, or size. A good place to start would be assessing epigenetic 
changes. In a recent study, acetylation of H4 and methylation of H3K9 were altered by 
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vitrification that may lead to abnormal epigenetic presentation of female chromatin to 
fertilization and may be responsible for the reduction of developmental competence of 
vitrified pig oocytes (Spinaci, 2012).  Both of these histone modifications could also be useful 
markers to monitor epigenetic perturbations induced by various experimental vitrification 
protocols and eventually for optimizing the cryopreservation of human oocytes (Yan, 2010). 
During these two experiments, many obstacles occurred and trouble shooting was 
necessary.  During both experiments there were possible problems with different protocols 
and media solutions. There are many protocols with different additives that contribute to the 
growth and development of oocytes and embryos. The exploration for a perfect maturation 
media for bovine oocytes alone could be an experiment and the search for the optimal culture 
for bovine embryos could also be extensively explored, including in vitro fertilization 
procedure. Amino acids, growth factors, different serum, a base buffer all could be altered and 
produce different results.  
In our isolate we found that it could be possibly causing DNA damage to sperm cells 
due to contamination with ions during sperm separation. The production of nitric oxide, is 
regarded as a sperm toxicant that reduces motility (Rosselli et. al, 1995). This could be due to 
an activation of guanylyl cyclase, that increases cGMP production, which inhibits sperm 
motility (Chan et. al, 1990). On the other hand, nitric oxide is also known to be a physiologic 
mediator for vasodilatation, immunosuppression, neurotransmission and cytotoxicity (Anggard 
et. al, 1994). This could cause poor fertility rates with the IVF protocol and embryo 
development (Nathanet. al, 1992). One of the main factors known to influence quality and 
fertility of bovine cryopreserved semen is the extender used. Despite the benefits of egg yolk 
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on semen cryopreservation, components of animal origin may represent a potential 
microbiological risk, compromising the quality of cryopreserved semen and standardization 
(Bousseau et. al, 1998). The egg yolk extender within the freezing media during this 
experiment could be resulting in complications in spermatozoa attaching and entering the 
zona pellucida for fertilization. In a recent study, lecithin, can be used in substitution for egg 
yolk as an extender (Forouzanfar et. al, 2010). We did see a significant difference between the 
IVF validation experiment and both treatments in both experiments in regard to fertilization 
despite using semen from the same bull. The quality of the sperm, extender and isolate used 
could produce lower results but was not observed during the results.  
Temperature sensitivity is always a problem that needs to be avoided during 
cryopreservation and thawing of cells, but it also can be a problem during collection of the 
bovine oocytes (Mortimer et. al, 2015). During collection the filter that holds the follicular fluid 
and oocytes are washed in a warmed holding media but are at room temperature for the 
collection period. The collection room is in doors and the rooms temperature is controlled. 
This change in temperature from the ovary to the warm media to cooling within the filter then 
back into warmed searching media could cause a problem with maturation and/or fertilization 
or aneuploidy due to chilling factors. In regard to the IVF validation oocytes, they were also 
collected but from a slaughter house. These procedures were done elsewhere so comparison 
with temperature sensitivity cannot be fairly measured to one another. The problem of 
maintaining temperature throughout the OPU and oocyte search procedure is an excellent 
illustration that not only do perceived problems represent opportunities for improvement.  
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There also is a possibility that the age of the cows can affect the quality of the collected 
oocytes within each experiment and the opportunity to become viable embryos. In one study 
results suggested that the fertilization ability of oocytes from older cows is low and that 
premature progression of meiotic division in oocytes is partly due to impaired oocyte-CC gap 
junction communication (Yamamoto et. al, 2010). Synchronizing the herd could have also 
helped retrieve larger and better quality oocytes within the follicles. During synchronization 
procedure the herd is reproductively synchronized to one another. This produces a new 
follicular wave to be created and releases a new dominant follicle. The better quality the 
oocytes the greater the chance they would become fertilized (Yamamoto, 2010).  After 
collection, the filter was searched for the oocytes and removed. During this experiment we 
used no scale or judgment on collected oocytes quality. No morphology features were 
evaluated to choose one oocyte over the other. Lonergan and colleagues demonstrated the 
effect of follicle size on bovine oocyte quality and developmental competence following 
maturation, fertilization and culture in vitro for porcine (Lonergan et. al, 2005) and concluded 
that oocytes from >6mm follicles yielded better results (Lonergan et. al, 2005). All oocytes 
collected were used in this experiment and this could have caused lower maturation rates and 
lower fertilization rates.  
Another option was to use a pre-IVM media. This may have increased the quality of 
maturation rather than holding them within HEPES-TALP after collection of oocytes for both 
experiments. Mitochondrial activity can be increased as well as the nuclear maturation and 
developmental competence, the amount of ICM cells increase, and the percentage of embryo 
development increases when using a pre-IVM culture (Huang et. al, 2014). In a recent study 
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Pre-IVM with FSK + IBMX increased subsequent blastocyst formation rate and quality 
compared with standard IVM (Li et. al, 2016).  Pre-IVM could have been an advantage during 
these experiments and may have improved our fertilization results. 
Overall, fertilization rates were uniformly low across treatment groups. While this 
could be due to the vitrification procedure, there are many other aspects that may have 
contributed to low fertilization. Initially this study faced many obstacles, which were overcome 
in a series of pre-trials to optimize the in vitro maturation and fertilization (as proven with our 
IVF validation experiment). As such, we believe that our results further show that vitrification 
still needs improvement to be efficient for bovine oocytes cryopreservation. However, results 













                                                             CHAPTER IV 




Oocyte cryopreservation is a reproductive technique that has been a useful tool for a 
number of industries, including livestock production, human infertility treatment, endangered 
species, preservation and stem cell research. Commercial and research industries depend on 
producing viable and developmentally competent oocytes and embryos for optimal success. It 
has been found that in vitro culture systems need to be improved to optimize oocyte and 
embryo quality and pregnancy rates and allowing for the wide spread of genetic resources 
(Rodriguez et. al, 2012) within cryopreservation. One example includes bovine zygotes 
cultured in vitro are capable of rates of development similar to those of in vivo cultured 
counterparts (in terms of day 8 blastocyst yield, cell number and early pregnancy rate), there 
were significant differences in embryo cryosurvival. This suggests that current in vitro culture 
systems need to be improved to optimize embryo quality and pregnancy rates (Enright et. al, 
2000). It has been demonstrated that there is a dramatic effect on blastocyst quality with 
those blastocysts produced following in vivo culture surviving vitrification at significantly 
higher rates than in vitro cultured counterparts (Rizos et. al, 2002). Successful 
cryopreservation of spermatozoa and embryos made assisted reproductive technologies more 
practical and available for commercial use, because of the potential advantages to allow long 
distance transportation and to avoid estrous synchronization. This reduces the size of the 
recipient female population necessary to be maintained. Cryopreservation of oocytes has short 
and less successful history when compared to the other reproductive cells such as 
spermatozoa and embryos.  Cryopreservation of unfertilized oocytes can be combined with 
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these advanced reproductive technologies, in addition to its potential advantage as oocyte 
banking for preserving female genetic resources. During maturation of an oocyte centromeres 
attach to the spindle fibers from the centrosome at the opposite poles in metaphase II and will 
not continue until fertilization occurs (Raven et. al, 2016). The most characterized cytoskeletal 
damage by cryopreservation concerns the disruption of sub-cortical actin network, 
microtubule depolymerization, abnormal spindle configuration and chromosome scattering 
within mature oocytes and therefore compromising the ability to develop into a viable embryo 
(Ferris et. al, 2015). Cryopreservation of germinal vesicle immature oocyte bypasses the risk of 
chromosome abnormalities as the chromatin is decondensed and is still protected by the 
nuclear envelope (Senger, 2005). However, cryopreservation of immature oocytes at the GV 
stage is also the subject for challenging endeavor. In many studies it has been shown that 
cryopreserving immature oocytes harms the ooplasm (Kim et. al, 2014), potentially due to 
inadequate conditions of in vitro maturation or basic oocyte defects. To date, with current 
protocols it may be best to cryopreserve mature oocytes after in vitro maturation to 
metaphase II (Combelles et al. 2012). Cryopreserving after maturation to metaphase II still 
leaves us with the issue of the spindle fibers being damaged during cryopreservation by ice 
crystal formation. 
 Cryoprotectant is the functionally derived term created to describe any additive which 
can be provided to cells before freezing to yield a higher post thaw survival and help reduce 
the amount of ice crystals formed within the cell. Cryoprotectants also help to ensure high 
levels of cell viability post thaw, and lower freezing temperatures allowing for greater 
dehydration of cells before water freezes (Watson, 1995). The most common cryoprotectants 
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used with embryos and oocyte cryopreservation are dimethyl sulfoxide and glycerol. Both of 
these cryoprotective agents are comparable to one another in many respects. In recent studies 
dimethyl sulfoxide has been used more often for oocytes and embryos (Schellander et. al, 
1994). In one particular study dimethyl sulfoxide treatment led to significantly better cleavage 
and development up to 4-cell stage in oocytes cryopreserved at the MII stage (Schellander et. 
al, 1994). In another study it was found that when using glycerol and 1,2- propanediol in 
vitrification of bovine blastocysts the success following the 16 step equilibration minimized the 
ultrastructural damage to the plasma membrane during freezing and therefore ice crystal 
formation (Kuwayama et. al, 1994). Depending on the source consulted, there have been 
variable results on the relative toxicity of the different cryoprotectants, with disagreement on 
which is the least or most toxic (Lawson and Sambanis, 2011). Many factors for optimizing 
cryopreservation are dependent on the cell type and species including cryoprotectants used 
experimental protocols and thawing time. 
CONCLUSION  
The results of the first experiment show a decrease in survival and development after 
vitrification and IVF. Fertilization rate in the first experiment of 8.49% DMSO vs 0% glycerol, 
were low and did have a significant difference between the two (p=0.0056) due to fertilization 
in the DMSO group and not within the glycerol treatment group. The results showing 
polyspermic fertilization in the first experiment (3.77%DMSO, 3.70% glycerol) may indicate a 
possibility that vitrification of oocytes is affecting the zona pellucida ability to become 
hardened after fertilization possibly disrupting the cortical granule reaction. Reiterating that 
cryopreservation of immature oocyte still has a way to go in optimizing protocols with the 
62 
 
majority degenerate after IVF (74.04% DMSO, 80.49% glycerol). In the second experiment we 
did have some progress in optimizing the vitrification protocol for bovine mature oocytes with 
the results showing DMSO having a significant difference in fertilization rate compared with 
glycerol (P=0.0056). Results also demonstrated that DMSO did recover the metaphase plate 
within the oocytes after vitrification at a higher rate than glycerol (29.12%, 13.63%, P value= 
0.0136) Overall, the majority of oocytes were degenerate like in the first experiment (45.63% 
DMSO, 56.82% glycerol) indicating vitrification and warming could be damaging oocytes.  
Future research is needed on the varying levels of cryopreservation via vitrification of 
immature and mature bovine oocytes. Specifically, on mature oocytes, while they 
demonstrated higher survival and fertilization rates in both treatment groups. For example, 
allowing vitrified mature oocytes to repair the spindles for a limited time after warming may 
allow for higher fertilization rates after IVF or the additional of calcium. DMSO induced calcium 
increases solely from the internal calcium pool was found that zona hardening significantly 
reduces and subsequent fertilization and development to the two cell stage significantly 
increased (Larman, 2006). Since zona hardening is one of the early activation events normally 
triggered by the sperm induced calcium increases observed at fertilization, it is possible that 
other processes are negatively affected by the calcium rise caused by cryoprotectants used 
during oocyte freezing, which might explain the current poor efficiency of this technique. 
There are still many aspects of oocyte cryopreservation that are not fully understood 
yet. Cryoprotectants are just one small factor in the big picture that involves many other 
pathways. Further research into the understanding of details of oocyte cryopreservation is 
necessary. This may help understand different protocols or factors influencing 
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cryopreservation and warming to increase the overall development and competence of oocyte 
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Vitrification for Bovine Oocytes 
1. Prepare equilibration and vitrification solutions before beginning (Appendix B). 
2. Place 3-5 oocytes in equilibration solution (solution one) 50uL drop for 5 minutes, 
pipette oocytes up, down and around dish for continued time during 5 minute interval. 
3. After 5 minutes in first solution move oocytes to second solution (50uL drop) for 35-40 
seconds, pipetting them around the dish.  
4. In the last 15 seconds of a total of 45 seconds in the second solution, pipette oocytes 
up and down and place on cryolock with minimal media. 
5. After oocytes are placed on the tip of the cryolock and media removed, plunge cryolock 
into liquid nitrogen and repeat until all oocytes are vitrified. 
6. With forceps, gently secure the top onto the cryolcok device under the liquid nitrogen.  
7. Move all cryolock with tops into canister for storage.  
In Vitro Fertilization for Bovine Oocytes 
Preparation: 
1. Place two centrifuge carriers into non CO2 incubator (39°C). 
2. Prepare IVF-TALP.  Check that there is warmed mineral oil in a CO2 incubator. 
3. Prepare 500µl of IVF-TALP in four well dish with water surrounding each well.  Prepare 
enough drops for the number of oocytes to be fertilized using 1 well per 15-20 oocytes. 
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Add 500 ul IVF-TALP in each well of a four well plate for use for washing. Equilibrate in 
CO2 incubator for at least 2-3 hours. 
4. Place tube with remaining IVF-TALP into the CO2 incubator (loosened cap). 
5. Prepare Percoll (Isolate) gradient.  Place 1.5 ml 90% lower layer in 15 ml centrifuge 
tube.  Carefully add 1.5 ml of 45% upper layer on top in a manner that does not cause 
mixing of the two layers. 
6. Transfer gradient to a pre-warmed centrifuge carrier in the non CO2 incubator.  
7. Add 95 ul water to a small centrifuge tube or use later with sperm counting (keep at 
room temperature). 
8. Wash hemacytometer and cover slip with alcohol and place on microscope. 
9. Clean microscope slides and coverslips and place on warming plate to use for checking 
motility later.  Place a microcentrifuge tube on warming plate to use for the sperm 
pellet later. 
Semen Thaw and Preparation of Sperm Suspension: 
1. Thaw semen in water bath at 39°C for 30 seconds being careful not to raise remaining 
straws in LN tank above the frost line. 
2. Dry straw and keep it warm.  Cut the sealed end off and, using a plunger carefully layer 
the semen on top of the percoll gradient in a manner that does not cause mixing. 
3. Check for motility of the thawed semen by placing a drop remaining in the straw on the 
pre-warmed slide.  View at 20X or 40X magnification to confirm motility.  If motility is 
not present prepare a new gradient and thaw another unit of semen.  
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4. Return the gradient with semen to the pre-warmed centrifuge carrier and centrifuge at 
400 xg for 20 minutes at 37°C. 
5. While the sperm is in the centrifuge, use this time to move the oocytes from 
maturation medium into IVF-TALP.  Wash oocytes through the IVF-TALP using the 
prepared wash dish from the CO2 incubator. 
6. Transfer 15-20 oocytes to each 500 ul drop of IVF-TALP in the fertilization dish and 
return fertilization dish to the CO2 incubator. 
7. With 2 minutes remaining on the centrifuge time, place 3 ml of IVF-TALP in a 15 ml 
centrifuge tube and return to CO2 incubator. 
8. When centrifugation is complete carefully remove carrier with gradient from the 
centrifuge.  There should be a sperm pellet in the bottom of the tube.  If not start over. 
9. With a 5 ml pipet, remove the extender (top layer) and the dead sperm (at the 
interphase). 
10. Collect 200 ul of sperm pellet from the bottom of the centrifuge tube and add slowly to 
the 3 ml of IVF-TALP. 
11. Centrifuge 400 xg for 10 minutes.  During this time add 2 ml of IVF-TALP to a new 15 ml 
centrifuge tube and return to the CO2 incubator. 
12. When centrifugation is complete remove ~ 3 ml of the medium from the top of the 
tube. 
13. Collect 200 ul of sperm pellet from the bottom of the centrifuge tube and add slowly to 
the 2 ml of IVF-TALP.   
14. Centrifuge 400 xg for 5 minutes. 
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15. Remove ~ 1 ml of medium from the top of the tube. 
16. With a 200 ul pipettor collect the pellet at the bottom of the tube.  Collect no more 
than the pellet and place in the pre-warmed sperm pellet tube.  Keep this tube on the 
warming plate until ready for fertilization. 
17. Determine the sperm pellet concentration: 
a.  Gently mix the sperm pellet and transfer 5 ul into the 95 ul water prepared earlier 
(1:20 dilution). 
b.  load each side of the hemacytometer with 10 ul of the diluted sperm.  Count  the 
sperm heads within five double-ruled squares on each side of the hemacytometer.  
These two counts should not vary more than 10%.  If they do clean the 
hemacytometer, reload and count again. 
18.  Prepare the final sperm suspension: 
a.  Average the two counts from above. This number (x) will be divided into 7500 to 
determine the µL of sperm pellet required to prepare the final suspension. Subtract this 
number from 300 to obtain the µL of IVF-TALP for the suspension. 
Eg:  7500/x = __µl sperm pellet ; 300 – __µ of sperm pellet = __µl of IVF-TALP. 
b.  Add the calculated amount of IVF-TALP to the pre-warmed micro centrifuge tube 
and then add the calculated amount of sperm pellet.  The final sperm suspension will 




1. To each fertilization drop with oocytes add 20 µl of Heparin stock. 
2. To each fertilization drop with oocytes add 20 µl of Penicillamine/Hypotarine (PH) 
stock. 
3. To each fertilization drop with oocytes add 20 µl of final sperm suspension for a final 
concentration of 1 x 106 sperm/ml in the fertilization drops. 
4. These last three steps should be done rapidly and the fertilization dishes returned to 
the CO2 incubator as rapidly as possible.  
Culture: 
1. Prepare culture dishes with 40uL droplets of global 35+ covered with mineral oil and 
wash droplets and place into 5% CO2 incubator at least 2 hours prior for equilibration.  
2. After 18 hours within 5% CO2 incubator, remove oocytes and place into 1mL centrifuge 
tube of hyaluronidase and vortex for 5-7 minutes to remove cumulus cells. 
3. When all cumulus cells removed, wash presumptive embryos in culture droplets and 
then transfer into fresh droplets for an additional 24 hours in 5% CO2 incubator.  
Aceto-Orcein Staining Protocol for Oocytes or Embryos 
1. Prepare aceto-orcein stain and methanol/acetic acid solution before beginning 
(Appendix B).  
2. Use a pencil to label the top of a microscope slide with the date, number of 
oocytes/embryos to be mounted, and any other relevant information.  
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3. Place small paraffin wax/vaseline posts onto each of the four sides of the coverslip.  
Place ≈10 oocytes/embryos onto the microscope slide, making sure none are on top of 
each other. Draw off excess medium as possible to ensure that they stick to the slide. 
4. Quickly place the coverslip onto the slide to prevent dehydration.  
5. While viewing the oocytes/embryos under the stereoscope, use a small stick or 
pencil to apply gentle pressure on each side of the coverslip at the posts. The 
oocytes/embryos should become slightly flattened to secure them in place but not 
mashed enough to break the zona. An air bubble will form around the oocyte when 
secured to the slide.  
5. Place rubber cement on two corners of the cover slip.  
6. Tilt the coplin jar containing methanol/acetic acid fixative, and gently submerse the 
slide into the solution. The rubber cement glue will harden on contact with the fixative.  
7. Stain and view after at least 48 hours of fixing. Slides can safely be stored in the coplin 
jars for up to 7 days. 
Staining:  
a. View between 48 hours and 7 days after mounting.  
b. Place one drop of aceto-orcein stain on one open side of the coverslip.  
c. Draw stain across the slide by placing a Kim wipe on the side of the coverslip 
opposite the drop of stain. An extra drop of stain can be placed on the slide to prevent 
the preparation from drying during viewing.  
d. Use microscope to view oocytes/embryos. Record observations and take 
photographs if necessary.  
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Hoechst 33342 Staining Protocol for Oocytes or Embryos 
1. Prepare Hoechst 33342 stain solution before beginning (Appendix B). 
2. Wash presumptive embryos 1x in PBS. 
3. Incubate for 30 minutes in 10 µL/ mL Hoechst 33342 in a 5% CO2 incubator at 37ᵒC. 
4. Rinse in Dulbecco’s Phosphate-Buffered Saline. 
5. Use a pencil to label the top of a microscope slide with the date, number of embryos 
to be mounted, and any other relevant information. 
6. Transfer presumptive embryos in a minimal amount of media, 8-10 embryos per 
slide.  
7. Add a 10 µL drop of Molecular Probes Prolong Gold Antifade (P36930) on top of 
presumptive embryos and gently place coverslip on top. 




























 Sterile filter. Date, label, and store at 4ᵒC for up to one week. 
 
IVF-TALP Medium 
Component Source Product Number Amount 
TL-FERT Caisson IVL02 22.5 mL 
PH Stock solution P-4875 / H-1384 1 mL 
1Heparin Stock solution H-3149 1 mL 
Pen/Strep Gibco 15140 250 uL 
Na Pyruvate Stock solution P-4562 250 uL 
BSA Sigma A-6003 150 mg 
 
Sterile, filter. Date, label and store at 4ᵒC for up to one week. 
 
Component Source Product Number Amount 
BSA, Fraction V Sigma A-4503 60 mg 
HEPES-TL Caisson IVL01 20 mL 
Na Pyruvate Stock solution P-4562 200 uL 
Pen/Strep Gibco 15140 200 uL 
Component Source Product Number Amount 
Medium-199 Sigma M-4530 8.68 mL 
Fetal Bovine Serum Cellgro 35-010-CV 1 mL 
Pen/Strep Gibco 15140 100 uL 
Na Pyruvate Stock solution P-4562 100 uL 
Glutamine 100x stock solution G-8540 100 uL 
FSH (Folltropin) 1000x stock solution Bioniche 10 uL 
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Vitrification Solution One for Glycerol  Vitrification Solution Two for Glycerol  
 
 




Vitrification Solution One for DMSO   Vitrification Solution Two for DMSO 
 
 




Dilution Solution for Warming 
 
PBS 16 mL 
20% Calf Serum 4 mL 
0.025 M Sucrose 0.855g 
  













PBS 3 mL  PBS 2 mL 
20% Calf Serum 1.0 mL  20% Calf Serum 1.0 mL 
10% Ethylene Glycol 0.5 mL  20% Ethylene Glycol 1.0 mL 
10% Glycerol 0.5 mL  20% Glycerol 1.0 mL 
0.5 M Sucrose 0.855g  0.5 M Sucrose 0.855g 
PBS 3 mL  PBS 2 mL 
20% Calf Serum 1.0 mL  20% Calf Serum 1.0 mL 
10% Ethylene Glycol 0.5 mL  20% Ethylene Glycol 1.0 mL 
10% DMSO 0.5 mL  20% DMSO 1.0 mL 
0.5 M Sucrose 0.855g  0.5 M Sucrose 0.855g 
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Stock Solutions:  
 
1. Dulbecco’s Phosphate-Buffered Saline: Add 100 mL of 10X D-PBS solution (Sigma D-1283) to 
900 mL of autoclaved DI water to make 1 L of D-PBS. Store at room temperature. Add 10 mL of 
Bovine Calf Serum (HyClone) and 1 mL of Heparin (Sagent Pharmaceuticals, Schaumburg, IL, 
USA) to make the D-PBS oocyte collection medium.  
 
2. Pen/Strep: Gibco 15140. Aliquot ≈500 μL of new pen/strep solution into sterile centrifuge 
tubes. Store at -20°C until use.  
 
3. Na Pyruvate: Sigma P-4562. Dissolve 22 mg of sodium pyruvate in 10 mL of sterile Millipore-
Q water. Sterile filter into an aluminum foil-wrapped 15 mL conical tube and store at 4°C for up 
to a month.  
 
4. L-Glutamine: Sigma G-8540. Make a 100X stock solution with a concentration of 200 mM by 
dissolving 2.92 g of glutamine in 100 mL of DI water. Aliquot 1.0 mL into sterile centrifuge tubes 
and store at -20°C.  
 
5. FSH: Folltropin-V (Bioniche). Make a 1000X stock solution (5 mg/mL) by diluting a 400 mg vial 
of folltropin in 80 mL of DI water. Store at -20°C in 100 μL aliquots.  
 
6. Hyaluronidase: Sigma H-3506. Prepare a 1 mg/mL solution by dissolving 10 mg hyaluronidase 
into 10 mL of HEPES-TALP (see media formulations above). Aliquot 1 mL into 1.5 mL sterile 
centrifuge tubes. Store at -80°C indefinitely.  
 
7. Methanol/Acetic Acid Fixative: For use with aceto-orcein staining protocol, make a 3:1 
methanol/acetic acid solution by adding 300 mL of methanol (Sigma M-1775) and 100 mL of 
acetic acid (Sigma A-6283). Store at room temperature.  
 
8. Aceto-Orcein stain: Prepare a 1% orcein stain by adding 100 mg of orcein (Sigma O-7380) to 
10 mL of solvent consisting of 60% DI water, 40% acetic acid (Sigma A-6283).  
 
9. Hoechst 33342: Dissolve 25 mg of Hoechst in 25 mL distilled water in a 50 mL centrifuge 
tube. Aliquot in 1 mL microcentrifuge tubes (1 mL / tube). Store at -20ᵒC for several months. For 
working solution in embryo culture or holding media dilute to 1 µg/mL. 
 
10.Heparin: Dissolve H-3149 1 mg Heparin into 20 mL of 0.9% saline and filter. Store -20°C 
 
11. PH: Combine 5 mL of 1 mM of Hypotourine and 5 mL of 2 mM Penicillamine to 8 mL of 0.9% 








 DETAILED OOCYTE ASSESSMENT BREAKDOWN 
 
 DMSO % (no.) Glycerol % (no.) P value  
Pronucleus  3.23%(6/104) 0%(0/82) 0.0352 
Two Pronuclei 2.15%(4/104) 0%(0/82) 0.1315 
Metaphase One 0%(0/104) 0.54%(1/82) 0.4409 
Metaphase Two 1.8%(2/104) 1.08%(2/82) 1.00 
Anaphase 0.54%(1-104) 0%(0/82) 1.00 
Polyspermy 2.15%(4-104) 3.23%(6/82) 0.3402 
Degenerate  41.40%(77/104) 35.48%(6/82) 0.3814 
Sperm and CC 6.45%(12/104) 3.23%(6/82) 0.4551 
 
 
Oocytes were analyzed in the following tables for nuclear status and development 
following fertilization. For experiment one, the indication of fertilization included formation of 
two pronuclei. Matured oocytes had either one pronucleus, a metaphase two plate or were 
anaphase stage. Immature group indicated oocytes in metaphase one, and polyspermy means 
polyspermy fertilization occurred. The degenerate variable means that the oocytes were dead. 
The indeterminate variable means that the oocytes were unknown, had sperm heads and/or 




Comparison of Nuclear Maturation in Exp. One, Immature Group with DMSO and Glycerol  
* Proportion with a probability value of P< 0.05 were considered significantly different  
 











Within the second experiment the categorization of oocyte development followed as 
fertilization included formation of two pronuclei, three cell and four cell embryo development. 
Matured oocytes had either one pronucleus, a metaphase two plate or were anaphase stage. 
Immature group indicated oocytes in metaphase one and germinal vesicles being present, and 
polyspermy means polyspermy fertilization occurred. The degenerate variable means that the 
oocytes were dead. The indeterminate variable means that the oocytes were unknown, had 






 DMSO % (no.) Glycerol % (no.) P value  
Pronucleus  4.71%(9/103) 2.62%(5/88) 0.5794 
Two Pronuclei 4.19%(8/103) 1.57%(3/88) 0.2292 
Metaphase One 0.52%(1/103) 0%(0/88) 1.00 
Metaphase Two 4.19%(8/103) 1.57%(3/88) 0.2292 
Anaphase 0%(0/103) 0.52%(1/88) 0.4607 
Polyspermy 0%(0/103) 1.57%(3/88) 0.0960 
Degenerate  24.61%(47/103) 26.18%(50/88) 0.1470 
Sperm and CC 10.99%(21/103) 11.52%(22/88) 0.4895 
Germinal Vesicle 2.09%(4/103) 0.52%(1/88) 0.3762 
Three Cell 1.56%(3/103) 0%(0/88) 0.2501 
Four Cell 1.05%(2/103) 0%(0/88) 0.5005 
Nuclear Maturation Breakdown of Oocytes/Embryos in Experiment Two 
 
Comparison of Nuclear Maturation in Exp. Two, Mature Group with DMSO and Glycerol  




Nuclear Maturation Breakdown of Oocytes by Replicate (Day) in Experiment One 


























1pronuclei  0 0 0 0 5 0 1 0 
2pronuclei 0 0 3 0 1 0 0 0 
Met1 0 0 0 1 0 0 0 0 
Met 2 0 0 2 2 0 0 0 0 
Anaphase 0 0 1 0 0 0 0 0 
Polyspermy 3 6 0 0 1 0 0 0 
Deg/unknown 2 4 14 10 35 33 27 19 
CC/Sperm 12 6 0 0 0 0 0 0 
 
Comparison of Nuclear Maturation in Exp. One, Immature Group with DMSO and Glycerol 
seperated by each replicate in numbers D(DMSO=104) G(Glycerol=82)  




Nuclear Maturation Breakdown of Oocytes by Replicate (Day) in Experiment Two 
 
 
 4-Nov(no.) 28-Oct(no.) 8-Dec(no.) 10-Dec(no.) 15-Dec(no.) 
 D G D G D G D G D G 
1pronuclei 4 2 0 0 1 1 1 1 3 1 
2pronuclei 0 0 0 0 1 1 3 0 4 2 
3 Cell 1 0 0 0 0 0 0 0 1 0 
4 Cell 1 0 0 0 1 0 0 0 0 0 
Met 1 0 0 0 0 0 0 1 0 0 0 
Met 2 4 3 0 0 1 0 3 0 0 0 
Anaphase 0 1 0 0 0 0 0 0 0 0 
Polyspermy 0 3 0 0 0 0 0 0 0 0 
Deg/unknown 13 7 19 17 7 10 4 11 4 5 
CC/Sperm 0 3 0 0 8 8 12 7 1 4 
GV  3 0 1 1 0 0 0 0 1 0 
 
Comparison of Nuclear Maturation in Exp. Two, Mature Group with DMSO and Glycerol 
seperated by each replicate in numbers D(DMSO=103), G(Glycerol=88)  
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